{"catalog": "D:\\project\\AspectMMKG\\Entities\\AstraZeneca\\Acquisition history", "query": "Entities\\AstraZeneca Acquisition history", "images": [{"img_url": "https://ichef.bbci.co.uk/news/624/mcs/media/images/74690000/jpg/_74690628_74690627.jpg", "img_caption": "AstraZeneca: A product of successful mergers? - BBC News"}, {"img_url": "https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41586-020-2798-3/MediaObjects/41586_2020_2798_Fig1_HTML.png", "img_caption": "SARS-CoV-2 vaccines in development | Nature"}, {"img_url": "https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41573-021-00195-4/MediaObjects/41573_2021_195_Fig1_HTML.png", "img_caption": "Kinase drug discovery 20 years after imatinib: progress and future  directions | Nature Reviews Drug Discovery"}, {"img_url": "https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fnrd.2017.244/MediaObjects/41573_2018_Article_BFnrd2017244_Fig1_HTML.jpg", "img_caption": "Impact of a five-dimensional framework on R&D productivity at AstraZeneca |  Nature Reviews Drug Discovery"}, {"img_url": "https://cdn.kscope.io/2be732b109e758f7b1512c626c73996b-g20179g05b12.jpg", "img_caption": "SEC Filing – Royalty Pharma"}]}
{"catalog": "D:\\project\\AspectMMKG\\Entities\\AstraZeneca\\Controversies", "query": "Entities\\AstraZeneca Controversies", "images": [{"img_url": "https://i0.wp.com/post.healthline.com/wp-content/uploads/2020/12/Astra_Zeneca_1296x728-header-1-1296x729.jpg?w=1155&h=2268", "img_caption": "What to Know About the AstraZeneca Vaccine Controversy"}, {"img_url": "https://post.healthline.com/wp-content/uploads/2020/12/Astra_Zeneca_1200x628-facebook-1200x628.jpg", "img_caption": "What to Know About the AstraZeneca Vaccine Controversy"}, {"img_url": "https://www.politico.com/dims4/default/19ccd86/2147483647/strip/true/crop/1160x773+0+0/resize/1290x860!/quality/90/?url=https%3A%2F%2Fstatic.politico.com%2Fd0%2Fda%2F50108d6b48e59a56f486d9596324%2Fgettyimages-1295000098-c.jpg", "img_caption": "New PR blunder undercuts AstraZeneca efforts to rebuild confidence in  vaccine - POLITICO"}, {"img_url": "https://i0.wp.com/post.healthline.com/wp-content/uploads/2020/12/Astra_Zeneca_1296x728-header-1-1296x729.jpg?w=1155&h=2268", "img_caption": "What to Know About the AstraZeneca Vaccine Controversy"}, {"img_url": "https://qtxasset.com/cdn-cgi/image/w=384,h=216,f=auto,fit=crop,g=0.5x0.5/https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1616674202/Coronavirus%20vaccine.jpg/Coronavirus%20vaccine.jpg?VersionId=gX3_dgudaldcSm2N0FsVsESm634iiURs", "img_caption": "AstraZeneca's COVID-19 vaccine defies data controversy with 76%  effectiveness in phase 3 | Fierce Pharma"}]}
{"catalog": "D:\\project\\AspectMMKG\\Entities\\AstraZeneca\\Controversies\\Bildman fraud, sexual harassment and faithless servant clawback", "query": "Entities\\AstraZeneca Bildman fraud, sexual harassment and faithless servant clawback", "images": [{"img_url": "https://secure.gravatar.com/avatar/33e05f5f2f936553bebe9ef36ddc032e?s=96&d=mm&r=g", "img_caption": "Faithless” Ex-CEO Forced to Give Back $6.8 Million in Compensation | Brody  And Associates, LLC"}, {"img_url": "https://expertinalllegalmatters.com/x/cdn/?https://storage.googleapis.com/production-sitelio-v1-0-5/395/200395/wLUsngiF/b8137626a7014d8d96594bef2a51b12f", "img_caption": "Coronavirus and 5G are linked"}, {"img_url": "https://expertinalllegalmatters.com/x/cdn/?https://storage.googleapis.com/production-sitelio-v1-0-5/395/200395/wLUsngiF/126da6aeea0b4b418f5201bcf97e6e7f", "img_caption": "Coronavirus and 5G are linked"}, {"img_url": "https://expertinalllegalmatters.com/x/cdn/?https://storage.googleapis.com/production-sitelio-v1-0-5/395/200395/wLUsngiF/6a83172a79c34590b1913db958f334fe", "img_caption": "Coronavirus and 5G are linked"}, {"img_url": "https://expertinalllegalmatters.com/x/cdn/?https://storage.googleapis.com/production-sitelio-v1-0-5/395/200395/wLUsngiF/324e782146a644148d639f0f14de3209", "img_caption": "Coronavirus and 5G are linked"}]}
{"catalog": "D:\\project\\AspectMMKG\\Entities\\AstraZeneca\\Controversies\\CAFÉ study", "query": "Entities\\AstraZeneca CAFÉ study", "images": [{"img_url": "https://www.future-science.com/cms/10.4155/fmc.09.24/asset/images/medium/graphic5.gif", "img_caption": "Growing significance of communities and collaboration in discovery and  development | Future Medicinal Chemistry"}, {"img_url": "https://oumnh.ox.ac.uk/sites/default/files/styles/mt_image_medium/public/oumnh/images/page/pd6b0_oq.jpeg?itok=cQU9qP3o", "img_caption": "Oxford vaccine pioneer comes face-to-face with 'our mortal enemy' in new  display of coronavirus sculpture | Oxford University Museum of Natural  History"}, {"img_url": "https://cbsnews3.cbsistatic.com/hub/i/r/2021/02/27/4814a8d7-9394-4737-a290-803cd4107ac2/thumbnail/1920x1080/d0a2cf69f027db5cbf6833b706775755/0226-cbsn-astrazeneca-ztf-655089-640x360.jpg", "img_caption": "Oxford-AstraZeneca researchers attempt to battle variants - CBS News"}, {"img_url": "https://cbsnews3.cbsistatic.com/hub/i/r/2021/05/01/db1a3eeb-2519-49f8-a39d-4b0ce8352ebf/thumbnail/1920x1080/c4f062237cb3483616c425b82fd35479/cbsn-fusion-will-astrazeneca-covid-vaccine-get-approved-in-us-thumbnail-705881-640x360.jpg", "img_caption": "Will AstraZeneca's COVID vaccine get approved in U.S.? - CBS News"}, {"img_url": "https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41436-021-01170-5/MediaObjects/41436_2021_1170_Figa_HTML.png", "img_caption": "Revised diagnostic criteria for neurofibromatosis type 1 and Legius  syndrome: an international consensus recommendation | Genetics in Medicine"}]}
{"catalog": "D:\\project\\AspectMMKG\\Entities\\AstraZeneca\\Controversies\\Conflicting commitments to the UK and the EU", "query": "Entities\\AstraZeneca Conflicting commitments to the UK and the EU", "images": [{"img_url": "https://static.dw.com/image/56361558_7.png", "img_caption": "Fact check: Is AstraZeneca in breach of its EU contract? | Europe | News  and current affairs from around the continent | DW | 27.01.2021"}, {"img_url": "https://eur-lex.europa.eu/resource.html?uri=comnat:COM_2021_0301_FIN.ENG.xhtml.COM_2021_0301_FIN_ENG_01004.jpg", "img_caption": "resource.html?uri=comnat:COM_2021_0301_FIN.ENG.xhtml.COM_2021_0301_FIN_ENG_01004.jpg"}, {"img_url": "https://www.city.ac.uk/__data/assets/image/0008/605951/varieties/breakpoint-max.jpg", "img_caption": "The EU-AstraZeneca Contract Dispute: A Nutshell Guide • City, University of  London"}, {"img_url": "https://www.bmj.com/content/bmj/371/bmj.m4750/F2.large.jpg", "img_caption": "Reserving coronavirus disease 2019 vaccines for global access: cross  sectional analysis | The BMJ"}, {"img_url": "https://www.bmj.com/content/bmj/371/bmj.m4750/F3.large.jpg", "img_caption": "Reserving coronavirus disease 2019 vaccines for global access: cross  sectional analysis | The BMJ"}]}
{"catalog": "D:\\project\\AspectMMKG\\Entities\\AstraZeneca\\Controversies\\Conflicting commitments to the UK and the EU", "query": "In August 2020 AstraZeneca declared towards the European Commission and the EU member states", "images": [{"img_url": "https://eur-lex.europa.eu/resource.html?uri=comnat:COM_2021_0301_FIN.ENG.xhtml.COM_2021_0301_FIN_ENG_01004.jpg", "img_caption": "resource.html?uri=comnat:COM_2021_0301_FIN.ENG.xhtml.COM_2021_0301_FIN_ENG_01004.jpg"}, {"img_url": "https://ichef.bbci.co.uk/news/640/cpsprodpb/6FE2/production/_116724682_vaccine_doses_per100_eu_countries_29jan-nc.png", "img_caption": "Covid: EU-AstraZeneca disputed vaccine contract made public - BBC News"}, {"img_url": "https://www.biopharma-reporter.com/var/wrbm_gb_food_pharma/storage/images/publications/pharmaceutical-science/biopharma-reporter.com/headlines/markets-regulations/astrazeneca-j-j-and-sanofi-gsk-set-to-sell-up-to-1.1bn-covid-19-vaccines-to-eu/11687564-1-eng-GB/AstraZeneca-J-J-and-Sanofi-GSK-set-to-sell-up-to-1.1bn-COVID-19-vaccines-to-EU.jpg", "img_caption": "AstraZeneca, J&J and Sanofi-GSK set to sell up to 1.1bn COVID-19 vaccines to  EU"}, {"img_url": "https://ec.europa.eu/info/sites/default/files/budget-resized.jpg", "img_caption": "March to August 2020 | European Commission"}, {"img_url": "https://ichef.bbci.co.uk/news/640/cpsprodpb/4763/production/_116657281_optimised-vaccine_rate_map_25jan-nc.png", "img_caption": "Coronavirus: EU demands UK-made AstraZeneca vaccine doses - BBC News"}]}
{"catalog": "D:\\project\\AspectMMKG\\Entities\\AstraZeneca\\Controversies\\Conflicting commitments to the UK and the EU", "query": "AstraZeneca represents", "images": [{"img_url": "https://pbs.twimg.com/media/B3NjQELCQAAC2qb.jpg", "img_caption": "AstraZeneca on Twitter: \"Infographic: non-small cell lung cancer represents  up to 85% of all #lungcancer #LCAM14 http://t.co/vlAJ2xTPAK\" / Twitter"}, {"img_url": "https://pbs.twimg.com/media/EDeD4hRUEAAHadL.jpg", "img_caption": "AstraZeneca on Twitter: \"#Heartfailure is a life-threatening disease in  which the heart cannot pump enough blood around the body and is commonly  linked to #type2diabetes. We're investigating ways to improve outcomes  through"}, {"img_url": "https://i.guim.co.uk/img/media/cdd8fdb1f3e24221e582e976f602b9979a93462f/53_0_3394_2037/master/3394.jpg?width=1200&quality=85&auto=format&fit=max&s=c6d9847a9260a1f631df8de4c7f05771", "img_caption": "AstraZeneca reviews diversity in trials to ensure drugs work for all |  AstraZeneca | The Guardian"}, {"img_url": "https://khn.org/wp-content/uploads/sites/2/2020/08/GettyImages-1227715002.jpg", "img_caption": "They Pledged to Donate Rights to Their COVID Vaccine, Then Sold Them to  Pharma | Kaiser Health News"}, {"img_url": "https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1607786883/PascalSoriot.jpg/PascalSoriot.jpg?VersionId=xQsto.6pn6Rdo9aHlMGNiQ8oYHQGqfek", "img_caption": "AstraZeneca snaps up Alexion for $39B in a leap toward CEO's $40B revenue  goal | Fierce Pharma"}]}
{"catalog": "D:\\project\\AspectMMKG\\Entities\\AstraZeneca\\Controversies\\Conflicting commitments to the UK and the EU", "query": "After placing the order for AstraZeneca's vaccine", "images": [{"img_url": "https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1613486439/GettyImages-1218961180.jpg/GettyImages-1218961180.jpg?VersionId=hEzf0Dj0592WN6emUlTg7hHjfVUIsB8_", "img_caption": "U.K. inspects AstraZeneca vaccine partner's India manufacturing, setting  stage for supply boost | Fierce Pharma"}, {"img_url": "https://images.newscientist.com/wp-content/uploads/2021/03/24163335/24-march_daily.jpg", "img_caption": "Why the UK changed covid-19 AstraZeneca vaccine advice for under-30s | New  Scientist"}, {"img_url": "https://images.theconversation.com/files/390491/original/file-20210318-19-1q6kytv.jpg?ixlib=rb-1.1.0&q=45&auto=format&w=1200&h=1200.0&fit=crop", "img_caption": "COVID vaccine weekly: AstraZeneca is safe and effective, but facing supply  issues"}, {"img_url": "https://www.openaccessgovernment.org/wp-content/uploads/2021/04/dreamstime_xxl_205879605-scaled.jpg", "img_caption": "One in four people get Pfizer and AstraZeneca vaccine side effects"}, {"img_url": "https://image.cnbcfm.com/api/v1/image/106837247-1612812492440-gettyimages-1301049485-kt2_7652_2021020852439085.jpeg?v=1622734681&w=1600&h=900", "img_caption": "Denmark suspends use of AstraZeneca Covid vaccine"}]}
{"catalog": "D:\\project\\AspectMMKG\\Entities\\AstraZeneca\\Controversies\\Conflicting commitments to the UK and the EU", "query": "the contract that AstraZeneca reached with the UK was very similar to that it reached with the EU", "images": [{"img_url": "https://dynaimage.cdn.cnn.com/cnn/c_fill,g_auto,w_1200,h_675,ar_16:9/https%3A%2F%2Fcdn.cnn.com%2Fcnnnext%2Fdam%2Fassets%2F210217142830-01-boris-johnson-astrazeneca-0217.jpg", "img_caption": "AstraZeneca's vaccine contract with the UK is based on 'best efforts,' just  like its deal with a frustrated EU | CNN"}, {"img_url": "https://ichef.bbci.co.uk/news/2048/cpsprodpb/7595/production/_119010103_optimised-vaccine_doses_per100_uk_us_eu_china_russia_21jun-nc-002.png", "img_caption": "Covid: What is happening with the EU vaccine rollout? - BBC News"}, {"img_url": "https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1644524563/GettyImages-1288838574.jpg/GettyImages-1288838574.jpg?VersionId=jMg8iPpcnuQy.Vl4ESzWW25xXQszjp7i", "img_caption": "AstraZeneca's COVID vaccine sales reached $4B last year, but don't expect  that much in 2022 | Fierce Pharma"}, {"img_url": "https://ichef.bbci.co.uk/news/976/cpsprodpb/17586/production/_116722659_mediaitem116722657.jpg", "img_caption": "Covid: EU-AstraZeneca disputed vaccine contract made public - BBC News"}, {"img_url": "https://ichef.bbci.co.uk/news/976/cpsprodpb/ECF6/production/_116726606_contract2.png", "img_caption": "Covid: EU-AstraZeneca disputed vaccine contract made public - BBC News"}]}
{"catalog": "D:\\project\\AspectMMKG\\Entities\\AstraZeneca\\Controversies\\Conflicting commitments to the UK and the EU", "query": "The key difference seems to be that AstraZeneca entered into a preliminary agreement with the U", "images": [{"img_url": "https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/c0547203-d7c7-4471-bd9b-1440f4613981/gr1_lrg.jpg", "img_caption": "Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against  SARS-CoV-2: an interim analysis of four randomised controlled trials in  Brazil, South Africa, and the UK - The Lancet"}, {"img_url": "https://pharmaceutical-journal.com/wp-content/uploads/2021/03/Covid-19-vaccines-mRNA-1-946x1024.png", "img_caption": "Everything you need to know about COVID-19 vaccines - The Pharmaceutical  Journal"}, {"img_url": "https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41586-020-2798-3/MediaObjects/41586_2020_2798_Fig1_HTML.png", "img_caption": "SARS-CoV-2 vaccines in development | Nature"}, {"img_url": "https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41541-021-00292-w/MediaObjects/41541_2021_292_Fig1_HTML.png", "img_caption": "SARS-CoV-2 vaccines strategies: a comprehensive review of phase 3  candidates | npj Vaccines"}, {"img_url": "https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/4f2c9c7f-f31c-4cb4-9bc2-562360324614/gr1.jpg", "img_caption": "Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a  prime-boost regimen in young and old adults (COV002): a single-blind,  randomised, controlled, phase 2/3 trial - The Lancet"}]}
{"catalog": "D:\\project\\AspectMMKG\\Entities\\AstraZeneca\\Controversies\\Nexium", "query": "Entities\\AstraZeneca Nexium", "images": [{"img_url": "https://www.empr.com/wp-content/uploads/sites/7/2018/12/0e9178716db9454c8a251bf1eac6e547-nexium_351145.jpg", "img_caption": "NEXIUM Dosage & Rx Info | Uses, Side Effects"}, {"img_url": "https://www.drugs.com/images/pills/mtm/Nexium%2020%20mg.jpg", "img_caption": "Generic Nexium Availability - Drugs.com"}, {"img_url": "https://5.imimg.com/data5/RQ/CC/EC/SELLER-6796833/nexium-500x500.jpg", "img_caption": "Esomeprazole Neksium 20mg, Astrazeneca, Prescription, Rs 150/box | ID:  21364190212"}, {"img_url": "https://www.wallstwatchdog.com/wp-content/uploads/2014/02/163113755.jpg", "img_caption": "AstraZeneca Says Nexium Is 'Still Safe' With Ranbaxy Ingredient"}, {"img_url": "https://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=f4853677-1622-4037-688b-fdf533a11d96&name=image-02.jpg", "img_caption": "NEXIUM® (esomeprazole magnesium) Prescribing Information | AZ Medical  Information"}]}
{"catalog": "D:\\project\\AspectMMKG\\Entities\\AstraZeneca\\Controversies\\Nexium", "query": "AstraZeneca patented S-omeprazole in pure form", "images": [{"img_url": "https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fnrd1010/MediaObjects/41573_2003_Article_BFnrd1010_Fig1_HTML.gif", "img_caption": "A proton-pump inhibitor expedition: the case histories of omeprazole and  esomeprazole | Nature Reviews Drug Discovery"}, {"img_url": "https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fnrd1010/MediaObjects/41573_2003_Article_BFnrd1010_Fig3_HTML.gif", "img_caption": "A proton-pump inhibitor expedition: the case histories of omeprazole and  esomeprazole | Nature Reviews Drug Discovery"}, {"img_url": "https://qtxasset.com/cdn-cgi/image/w=384,h=216,f=auto,fit=crop,g=0.5x0.5/https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1627904994/Saphnelo.jpg?VersionId=ClDwMJRyzPHXk1gjIVSZwlRXGlzDKYUH", "img_caption": "AstraZeneca nabs FDA nod to challenge GSK's Benlysta with first-in-class  lupus drug Saphnelo | Fierce Pharma"}, {"img_url": "https://pubchem.ncbi.nlm.nih.gov/image/imgsrv.fcgi?cid=9568614&t=l", "img_caption": "Esomeprazole | C17H19N3O3S - PubChem"}, {"img_url": "https://patentimages.storage.googleapis.com/6f/50/08/a17138dbb9c34f/imgf000005_0001.png", "img_caption": "WO2005080374A1 - New compounds useful for the synthesis of s- and r- omeprazole and a process for their preparation - Google Patents"}]}
{"catalog": "D:\\project\\AspectMMKG\\Entities\\AstraZeneca\\Controversies\\Nexium", "query": "that AstraZeneca's scientists had misrepresented their research on the drug's efficiency", "images": [{"img_url": "https://images.nature.com/original/magazine-assets/d41586-020-03334-w/d41586-020-03334-w_18619022.jpg", "img_caption": "The COVID vaccine challenges that lie ahead"}, {"img_url": "https://media-cldnry.s-nbcnews.com/image/upload/newscms/2021_10/3456293/210312-astrazeneca-mc-947.JPG", "img_caption": "Oxford-AstraZeneca vaccine delays over blood clot fears raise new doubts  over Europe's rollout"}, {"img_url": "https://thehill.com/wp-content/uploads/sites/2/2020/11/astrazenecavaccine.jpg", "img_caption": "Oxford researchers pause trial of COVID-19 vaccine in children, teenagers |  The Hill"}, {"img_url": "https://i.guim.co.uk/img/media/e7ad0580edb13304a95d4bf7baf97e4628861127/0_172_3500_2101/master/3500.jpg?width=620&quality=85&fit=max&s=c064b888b61b4403e8fd9622371aeb6c", "img_caption": "How the AstraZeneca vaccine became a political football – and a PR disaster  | AstraZeneca | The Guardian"}, {"img_url": "https://media.cnn.com/api/v1/images/stellar/prod/210324185503-astrazeneca-covid-19-vaccine-france-0206.jpg?q=x_2,y_176,h_1123,w_1995,c_crop/h_270,w_480", "img_caption": "How AstraZeneca went from pandemic hero to villain | CNN Business"}]}
{"catalog": "D:\\project\\AspectMMKG\\Entities\\AstraZeneca\\Controversies\\Seroquel", "query": "Entities\\AstraZeneca Seroquel", "images": [{"img_url": "https://www.clinicaltrialsarena.com/wp-content/uploads/sites/22/2019/07/1-seroquel-treatment.jpg", "img_caption": "Seroquel - Treatment for Major Depressive Disorder (MDD) - Clinical Trials  Arena"}, {"img_url": "https://www.gnhindia.com/wp-content/uploads/2020/04/setid473a3ac4-67f4-4782-baa9-7f9bdd8761f4nameimage-05.jpg", "img_caption": "BUY quetiapine fumarate - XR (SEROQUEL) 50 mg/1 AstraZeneca Pharmaceuticals  LP"}, {"img_url": "https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2019/10/Seroquel-800x418.jpg", "img_caption": "AstraZeneca to sell European and Russian rights for Seroquel"}, {"img_url": "https://www.drugs.com/images/pills/mmx/t108861f/seroquel-xr.jpg", "img_caption": "Generic Seroquel XR Availability - Drugs.com"}, {"img_url": "https://www.drugs.com/pro/images/0584dda8-bc3c-48fe-1a90-79608f78e8a0/NDC0310-0275-10.jpg", "img_caption": "Seroquel - FDA prescribing information, side effects and uses"}]}
{"catalog": "D:\\project\\AspectMMKG\\Entities\\AstraZeneca\\Controversies\\Seroquel", "query": "AstraZeneca settled a qui tam lawsuit brought by Stefan P", "images": [{"img_url": "https://sheller.com/wp-content/uploads/2021/03/Screen-Shot-2021-03-04-at-5.53.04-PM.png", "img_caption": "whistleblower – Sheller, P.C. Law Firm"}, {"img_url": "https://upload.wikimedia.org/wikipedia/commons/thumb/b/bf/AstraZeneca_HQ_in_Cambridge_UK.jpg/1200px-AstraZeneca_HQ_in_Cambridge_UK.jpg", "img_caption": "AstraZeneca - Wikipedia"}, {"img_url": "https://www.gibsondunn.com/publications/PublishingImages/2014-YrEnd-FCA1.jpg", "img_caption": "2014 Year-End False Claims Act Update - Gibson Dunn"}, {"img_url": "https://www.gibsondunn.com/publications/PublishingImages/2014-YrEnd-FCA2.jpg", "img_caption": "2014 Year-End False Claims Act Update - Gibson Dunn"}, {"img_url": "https://upload.wikimedia.org/wikipedia/commons/8/88/Stefan_P_Kruszewski_MD.jpg", "img_caption": "Stefan P. Kruszewski - Wikipedia"}]}
{"catalog": "D:\\project\\AspectMMKG\\Entities\\AstraZeneca\\Controversies\\Seroquel", "query": "AstraZeneca targeted its illegal marketing of the anti-psychotic Seroquel towards doctors who do not typically treat schizophrenia or bipolar disorder", "images": [{"img_url": "https://arc-anglerfish-washpost-prod-washpost.s3.amazonaws.com/public/L3JC33A5VAI6RHPBCR65FXZYFE.jpg", "img_caption": "Popular drug Seroquel, first meant for schizophrenia, reveals 'off-label'  issues - The Washington Post"}, {"img_url": "https://pbs.twimg.com/media/EnvENbbXEAAa4zV.png", "img_caption": "सिद्धार्थ on Twitter: \"🤔Can we take @AstraZeneca's claims @ face value? A  thread. 👉AstraZeneca became a truly multinational company when  British-owned Zeneca Group merged w/ the Swedish company Astra AB in 1999."}, {"img_url": "https://i1.wp.com/business-ethics.com/wp-content/uploads/2010/04/Seroquel-Tablets.jpg?fit=253%2C221&ssl=1", "img_caption": "AstraZeneca to Pay $520 Million to Settle Illegal Marketing Charges |  Business Ethics"}, {"img_url": "https://www.medgadget.com/wp-content/uploads/2021/11/anti-psychotic-drugs-market-scaled.jpg", "img_caption": "Best Research Report on Antipsychotic Drugs Market by Forecast to 2027 with  Covid-19 Impact, Current and Future Growth Overview, Competitor Analysis |  AstraZeneca, Pfizer, Inc., Eli Lily and Co., Bristol- Myers Squibb |  Medgadget"}, {"img_url": "https://arc-anglerfish-washpost-prod-washpost.s3.amazonaws.com/public/K7WTGPA5VAI6RHPBCR65FXZYFE.jpg", "img_caption": "Popular drug Seroquel, first meant for schizophrenia, reveals 'off-label'  issues - The Washington Post"}]}
{"catalog": "D:\\project\\AspectMMKG\\Entities\\AstraZeneca\\Controversies\\Seroquel", "query": "AstraZeneca settled a lawsuit in the United States totalling US$68", "images": [{"img_url": "https://imgv2-2-f.scribdassets.com/img/document/52406239/298x396/8e23b9fb7b/1302092623?v=1", "img_caption": "MMS Project Guidelines Revised | PDF | Generic Drug | Pharmaceutical  Sciences"}, {"img_url": "https://s3.studylib.net/store/data/008384776_1-465ce0a37691c07343ea607794282434-768x994.png", "img_caption": "A GLOBAL PERSPECTIVE"}, {"img_url": "https://image.isu.pub/210105041004-c56702ed75539313b09480fb5030df5c/jpg/page_1_thumb_large.jpg", "img_caption": "Guyana Times - Tuesday, January 5, 2021 by Gytimes - Issuu"}, {"img_url": "https://imgv2-2-f.scribdassets.com/img/document/52406239/298x396/8e23b9fb7b/1302092623?v=1", "img_caption": "MMS Project Guidelines Revised | PDF | Generic Drug | Pharmaceutical  Sciences"}, {"img_url": "https://s3.studylib.net/store/data/008384776_1-465ce0a37691c07343ea607794282434-768x994.png", "img_caption": "A GLOBAL PERSPECTIVE"}]}
{"catalog": "D:\\project\\AspectMMKG\\Entities\\AstraZeneca\\Controversies\\Transfer mispricing", "query": "Entities\\AstraZeneca Transfer mispricing", "images": [{"img_url": "https://transferpricingasia.com/wp-content/uploads/2017/01/what-is-transfer-pricing-controlled-transactions.jpg", "img_caption": "What Is Transfer Pricing? | A Clear And Simple Definition"}, {"img_url": "https://i.guim.co.uk/img/static/sys-images/Business/Pix/pictures/2011/3/28/1301307772510/Nexium-an-AstraZeneca-dru-007.jpg?width=1200&height=630&quality=85&auto=format&fit=crop&overlay-align=bottom%2Cleft&overlay-width=100p&overlay-base64=L2ltZy9zdGF0aWMvb3ZlcmxheXMvdGctZGVmYXVsdC5wbmc&enable=upscale&s=fadd116dafbefb6ee9ee9733517eeb45", "img_caption": "AstraZeneca settles tax dispute and saves $1bn | AstraZeneca | The Guardian"}, {"img_url": "https://assets.euromoneydigital.com/dims4/default/e71f366/2147483647/strip/true/crop/400x100+0+0/resize/800x200!/quality/90/?url=http%3A%2F%2Feuromoney-brightspot.s3.amazonaws.com%2F77%2F53%2F863de2d8124d245f06c791f4c905%2Fastrabig.gif", "img_caption": "AstraZeneca fights HMRC over transfer pricing | International Tax Review"}, {"img_url": "https://transferpricingasia.com/wp-content/uploads/2017/01/what-is-transfer-pricing-uncontrolled-transaction.jpg", "img_caption": "What Is Transfer Pricing? | A Clear And Simple Definition"}, {"img_url": "https://assets.euromoneydigital.com/dims4/default/cbf8090/2147483647/strip/true/crop/178x100+111+0/resize/1200x675!/quality/90/?url=http%3A%2F%2Feuromoney-brightspot.s3.amazonaws.com%2F77%2F53%2F863de2d8124d245f06c791f4c905%2Fastrabig.gif", "img_caption": "AstraZeneca fights HMRC over transfer pricing | International Tax Review"}]}
{"catalog": "D:\\project\\AspectMMKG\\Entities\\AstraZeneca\\Controversies\\Transfer mispricing", "query": "AstraZeneca agreed to pay £505 million to settle a UK tax dispute related to transfer mispricing", "images": [{"img_url": "https://i.guim.co.uk/img/static/sys-images/Society/Pix/pictures/2008/04/08/pharmacy.jpg?width=1200&height=630&quality=85&auto=format&fit=crop&overlay-align=bottom%2Cleft&overlay-width=100p&overlay-base64=L2ltZy9zdGF0aWMvb3ZlcmxheXMvdGctYWdlLTIwMTAucG5n&enable=upscale&s=2cdf765d8b6f36c22b0fe32b35193083", "img_caption": "AstraZeneca agrees to pay £505m to settle UK tax dispute | AstraZeneca |  The Guardian"}, {"img_url": "https://image.cnbcfm.com/api/v1/image/35125259-astrazeneca_200.jpg?v=1354732729&w=1600&h=900", "img_caption": "AstraZeneca Pays $1 Billion in US Tax Dispute"}, {"img_url": "https://i.guim.co.uk/img/media/b23bfda10072da164b713d73dc4f17c96da5e9b7/0_24_3600_2161/500.jpg?quality=85&auto=format&fit=max&s=6519af85f03f76a1a11932c577e471d8", "img_caption": "AstraZeneca agrees to pay £505m to settle UK tax dispute | AstraZeneca |  The Guardian"}, {"img_url": "https://i.guim.co.uk/img/static/sys-images/Business/Pix/pictures/2011/3/28/1301307772510/Nexium-an-AstraZeneca-dru-007.jpg?width=620&quality=85&fit=max&s=6a9d3a30d3f22827e984d85f84c84125", "img_caption": "AstraZeneca settles tax dispute and saves $1bn | AstraZeneca | The Guardian"}, {"img_url": "https://i.guim.co.uk/img/static/sys-images/Guardian/Pix/pictures/2014/5/18/1400434424362/Pfizer-011.jpg?width=300&quality=85&auto=format&fit=max&s=686944990c64a7727e4c4ac124d16f97", "img_caption": "AstraZeneca agrees to pay £505m to settle UK tax dispute | AstraZeneca |  The Guardian"}]}
{"catalog": "D:\\project\\AspectMMKG\\Entities\\AstraZeneca\\External links", "query": "Entities\\AstraZeneca External links", "images": [{"img_url": "https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fnrd.2017.244/MediaObjects/41573_2018_Article_BFnrd2017244_Fig1_HTML.jpg", "img_caption": "Impact of a five-dimensional framework on R&D productivity at AstraZeneca |  Nature Reviews Drug Discovery"}, {"img_url": "https://www.bmj.com/content/bmj/371/bmj.m4750/F2.medium.jpg", "img_caption": "Reserving coronavirus disease 2019 vaccines for global access: cross  sectional analysis | The BMJ"}, {"img_url": "https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fnrd4309/MediaObjects/41573_2014_Article_BFnrd4309_Fig1_HTML.jpg", "img_caption": "Lessons learned from the fate of AstraZeneca's drug pipeline: a  five-dimensional framework | Nature Reviews Drug Discovery"}, {"img_url": "https://ichef.bbci.co.uk/news/640/cpsprodpb/988F/production/_116155093_vaccine_funding_2x640-nc.png", "img_caption": "Covid vaccines: Will drug companies make bumper profits? - BBC News"}, {"img_url": "https://www.bmj.com/content/bmj/371/bmj.m4750/F3.medium.jpg", "img_caption": "Reserving coronavirus disease 2019 vaccines for global access: cross  sectional analysis | The BMJ"}]}
{"catalog": "D:\\project\\AspectMMKG\\Entities\\AstraZeneca\\External links", "query": "Media related to AstraZeneca at Wikimedia Commons Official website", "images": [{"img_url": "https://qtxasset.com/cdn-cgi/image/w=384,h=216,f=auto,fit=crop,g=0.5x0.5/https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1629897174/JNJIOffice3.jpg/JNJIOffice3.jpg?VersionId=i0nrA3YfxCU4wPlL8LYZyAI_udnSEOfr", "img_caption": "Johnson & Johnson touts antibody response for COVID-19 booster 8 months  after original vaccination | Fierce Pharma"}, {"img_url": "https://images.theconversation.com/files/470339/original/file-20220622-11-hea4if.jpg?ixlib=rb-1.1.0&rect=0%2C58%2C6552%2C3271&q=45&auto=format&w=668&h=324&fit=crop", "img_caption": "AstraZeneca vaccine – News, Research and Analysis – The Conversation – page  1"}, {"img_url": "https://qtxasset.com/cdn-cgi/image/w=384,h=216,f=auto,fit=crop,g=0.5x0.5/https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1601652868/Stephane_Bancel.png/Stephane_Bancel.png?VersionId=NNpZvo09HtvUppchWt6C_Qve4KsiID4J", "img_caption": "Moderna CEO says coronavirus vaccine won't be ready for FDA till late  November: FT | Fierce Pharma"}, {"img_url": "https://www.umhs-sk.org/hs-fs/hubfs/Moderna%20vax.jpg?width=1024&name=Moderna%20vax.jpg", "img_caption": "UMHS COVID-19 experts on vaccine facts & fallacies"}, {"img_url": "https://www.science.org/cms/10.1126/science.371.6524.10/asset/22c178ef-4d0d-494c-b990-359dcc30ec26/assets/graphic/371_10_f1.jpeg", "img_caption": "Pfizer's vaccine raises allergy concerns"}]}
{"catalog": "D:\\project\\AspectMMKG\\Entities\\AstraZeneca\\History", "query": "Entities\\AstraZeneca History", "images": [{"img_url": "https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41586-020-2798-3/MediaObjects/41586_2020_2798_Fig1_HTML.png", "img_caption": "SARS-CoV-2 vaccines in development | Nature"}, {"img_url": "https://gh.bmj.com/content/bmjgh/6/12/e007321/F1.large.jpg", "img_caption": "Who funded the research behind the Oxford–AstraZeneca COVID-19 vaccine? |  BMJ Global Health"}, {"img_url": "https://pharmaphorum.com/wp-content/uploads/2012/08/Astrazeneca.jpg", "img_caption": "A history of AstraZeneca"}, {"img_url": "https://cloudfront-us-east-2.images.arcpublishing.com/reuters/OIR64FXC6VJLJNDE5TZNEZMRNQ.jpg", "img_caption": "U.S. FDA authorizes use of AstraZeneca COVID-19 antibody cocktail | Reuters"}, {"img_url": "https://www.drugwatch.com/wp-content/uploads/astrazeneca-logo-sm.png", "img_caption": "AstraZeneca - Review of Drug Manufacturer"}]}
{"catalog": "D:\\project\\AspectMMKG\\Entities\\AstraZeneca\\History", "query": "in 1999 Astra and Zeneca Group merged to form AstraZeneca plc", "images": [{"img_url": "https://www.drugwatch.com/wp-content/uploads/astrazeneca-logo-sm.png", "img_caption": "AstraZeneca - Review of Drug Manufacturer"}, {"img_url": "https://pharmaphorum.com/wp-content/uploads/2012/08/Astrazeneca.jpg", "img_caption": "A history of AstraZeneca"}, {"img_url": "https://ichef.bbci.co.uk/news/624/mcs/media/images/74690000/jpg/_74690628_74690627.jpg", "img_caption": "AstraZeneca: A product of successful mergers? - BBC News"}, {"img_url": "https://upload.wikimedia.org/wikipedia/commons/thumb/f/f0/Astrahassleentrance.JPG/1024px-Astrahassleentrance.JPG", "img_caption": "AstraZeneca - Review of Drug Manufacturer"}, {"img_url": "https://res.cloudinary.com/crunchbase-production/image/upload/c_lpad,f_auto,q_auto:eco,dpr_1/v1492084539/k70fkhka0bgkud4cecpz.png", "img_caption": "AstraZeneca - Crunchbase Company Profile & Funding"}]}
{"catalog": "D:\\project\\AspectMMKG\\Entities\\AstraZeneca\\History", "query": "AstraZeneca identified a new location for the company's US base", "images": [{"img_url": "https://khn.org/wp-content/uploads/sites/2/2020/08/GettyImages-1227715002.jpg", "img_caption": "They Pledged to Donate Rights to Their COVID Vaccine, Then Sold Them to  Pharma | Kaiser Health News"}, {"img_url": "https://www.statnews.com/wp-content/uploads/2020/06/AP_20020584953238-645x645.jpg", "img_caption": "AstraZeneca's ambitious vaccine dreams are finally, officially dead - STAT"}, {"img_url": "https://static.dw.com/image/17608482_6.jpg", "img_caption": "AstraZeneca COVID vaccine′s complex EU supply chain | Business | Economy  and finance news from a German perspective | DW | 02.02.2021"}, {"img_url": "https://www.gannett-cdn.com/media/2021/02/12/USATODAY/usatsports/247WallSt.com-247WS-837959-imageForEntry8-MMs.jpg?crop=1365,768,x0,y0&width=1365&height=768&format=pjpg&auto=webp", "img_caption": "AstraZeneca COVID-19 vaccine prematurely halted in Europe: US experts"}, {"img_url": "https://www.drugwatch.com/wp-content/uploads/astrazeneca-rd-site-640x0-c-default.jpg", "img_caption": "AstraZeneca - Review of Drug Manufacturer"}]}
{"catalog": "D:\\project\\AspectMMKG\\Entities\\AstraZeneca\\History\\2000–06", "query": "Entities\\AstraZeneca 2000–06", "images": [{"img_url": "https://www.science.org/cms/10.1126/scitranslmed.aaa3679/asset/54b56636-7075-4f2c-b4b8-acef53abe225/assets/graphic/7286ps12_f1.jpeg", "img_caption": "How to handle an industry in disruption: Intervene or laissez-faire?"}, {"img_url": "https://healthpolicy.usc.edu/wp-content/uploads/2021/10/Fig.-1.1.png", "img_caption": "The 340B Drug Pricing Program: Background, Ongoing Challenges and Recent  Developments – USC Schaeffer"}, {"img_url": "https://www.nejm.org/na101/home/literatum/publisher/mms/journals/content/nejm/2021/nejm_2021.385.issue-3/nejmp2107528/20210712/images/img_medium/nejmp2107528_f1.jpeg", "img_caption": "Averting Future Vaccine Injustice | NEJM"}, {"img_url": "https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41429-020-0291-8/MediaObjects/41429_2020_291_Fig1_HTML.png", "img_caption": "Antibiotics in the clinical pipeline in October 2019 | The Journal of  Antibiotics"}, {"img_url": "https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1638789596/original.png/original.png?VersionId=WV0K0MM1UrRwIDgaRHPeEsdKdWn1ycGQ", "img_caption": "AstraZeneca weighs spinning out COVID-19 products into separate company:  Bloomberg | Fierce Pharma"}]}
{"catalog": "D:\\project\\AspectMMKG\\Entities\\AstraZeneca\\History\\2000–06", "query": "a former director of AstraZeneca", "images": [{"img_url": "https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1645538786/soriot.jpg/soriot.jpg?VersionId=JRcSIMRe5WiFc4v6cJqrnGAF1ijFOYk3", "img_caption": "AstraZeneca CEO snared more than $18M last year as his company worked  through highs and lows of vaccine launch | Fierce Pharma"}, {"img_url": "https://d1e00ek4ebabms.cloudfront.net/production/5ba8e6cd-1062-438b-bda5-b62c50fb1e84.jpg", "img_caption": "Drug wars: how AstraZeneca overtook GSK in UK pharma | Financial Times"}, {"img_url": "https://qtxasset.com/cdn-cgi/image/w=384,h=216,f=auto,fit=crop,g=0.5x0.5/https://qtxasset.com/quartz/qcloud5/media/image/2017-06/Luke%20Miels%20GlaxoSmithKline.jpg?VersionId=RRFE5rr8mwf7iC4HakQmyvw0aiVAPXvi", "img_caption": "GlaxoSmithKline gets AstraZeneca to finally release former executive Miels,  in two more months | Fierce Pharma"}, {"img_url": "https://d1e00ek4ebabms.cloudfront.net/production/486e473b-f666-40e2-8c80-dc12e43430f7.jpg", "img_caption": "Disputes leave AstraZeneca boss with chronic vaccine headache | Financial  Times"}, {"img_url": "http://prod-upp-image-read.ft.com/394ace9c-6243-11e7-8814-0ac7eb84e5f1", "img_caption": "Pascal Soriot to remain at AstraZeneca | Financial Times"}]}
{"catalog": "D:\\project\\AspectMMKG\\Entities\\AstraZeneca\\History\\2000–06", "query": "AstraZeneca acquired Cambridge Antibody Technology for £702 million", "images": [{"img_url": "https://cdn.sanity.io/images/0vv8moc6/pharmtech/f432d9dcd3c0d59c9cd9bcec9828d4d8ded512e5-1280x720.jpg?w=250&fit=crop&auto=format", "img_caption": "AstraZeneca to Buy Cambridge Antibody Technology"}, {"img_url": "https://www.cam.ac.uk/sites/www.cam.ac.uk/files/shorthand/204192/MSlrrwvmLF/assets/W0KA9YrweC/campath-molecule-2560-by1440_banner-11-2560x1440.jpeg", "img_caption": "A very Cambridge story\""}, {"img_url": "https://www.cam.ac.uk/sites/www.cam.ac.uk/files/shorthand/204192/MSlrrwvmLF/assets/5X8aFaLWQ4/campath-molecule-2560-by1440_banner-10-2560x1440.jpeg", "img_caption": "A very Cambridge story\""}, {"img_url": "https://www.cam.ac.uk/sites/www.cam.ac.uk/files/shorthand/204192/MSlrrwvmLF/assets/KhhFpbYQyo/campath-molecule-2560-by1440_banner-12-2560x1440.jpeg", "img_caption": "A very Cambridge story\""}, {"img_url": "https://www.cam.ac.uk/sites/www.cam.ac.uk/files/shorthand/204192/MSlrrwvmLF/assets/Bf52IhavLZ/greg_4_2560-by-1440_2-2396x1348.jpeg", "img_caption": "A very Cambridge story\""}]}
{"catalog": "D:\\project\\AspectMMKG\\Entities\\AstraZeneca\\History\\2007–12  The patent cliff and subsequent acquisitions", "query": "Entities\\AstraZeneca 2007–12  The patent cliff and subsequent acquisitions", "images": [{"img_url": "https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs40064-016-2323-1/MediaObjects/40064_2016_2323_Fig1_HTML.gif", "img_caption": "Patent cliff and strategic switch: exploring strategic design possibilities  in the pharmaceutical industry | SpringerPlus | Full Text"}, {"img_url": "https://d2cbg94ubxgsnp.cloudfront.net/Pictures/480xAny/7/4/2/124742_news-p13-400_tcm18-141285.jpg", "img_caption": "Pharma refocuses on the patent cliff | News | Chemistry World"}, {"img_url": "https://www.science.org/cms/asset/ddf8b12a-8256-467a-b6ff-bc019e18cf56/7286ps12_f1.gif", "img_caption": "How to handle an industry in disruption: Intervene or laissez-faire?"}, {"img_url": "https://qtxasset.com/cdn-cgi/image/w=384,h=216,f=auto,fit=crop,g=0.5x0.5/https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1624409644/patent_image_0.jpg/patent_image_0.jpg?VersionId=F75jLNs3Z0Vz4P2XTnrh1EDWHQpkVe2R", "img_caption": "The top 15 blockbuster patent expirations coming this decade | Fierce Pharma"}, {"img_url": "https://d2cbg94ubxgsnp.cloudfront.net/Pictures/480xAny/7/4/1/124741_news-p12-400_tcm18-141284.jpg", "img_caption": "Pharma refocuses on the patent cliff | News | Chemistry World"}]}
{"catalog": "D:\\project\\AspectMMKG\\Entities\\AstraZeneca\\History\\2007–12  The patent cliff and subsequent acquisitions", "query": "AstraZeneca agreed to buy Arrow Therapeutics", "images": [{"img_url": "https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41591-021-01463-x/MediaObjects/41591_2021_1463_Fig1_HTML.png", "img_caption": "A 'mix and match' approach to SARS-CoV-2 vaccination | Nature Medicine"}, {"img_url": "https://pharmaphorum.com/wp-content/uploads/2012/08/Astrazeneca.jpg", "img_caption": "A history of AstraZeneca"}, {"img_url": "https://assets.bwbx.io/images/users/iqjWHBFdfxIU/itztHy5g7GLY/v3/-1x-1.jpg", "img_caption": "AstraZeneca Outlook Raised as Covid Therapies Offset Vaccine Drop (LON:AZN)  - Bloomberg"}, {"img_url": "https://media-exp1.licdn.com/dms/image/C4E0BAQGNOjiwyqZVJw/company-logo_200_200/0/1519855878148?e=2147483647&v=beta&t=S_U_5IyXi2gYtAi7mwGt05kT8FFe2Yk5jQ6zx9ZOveQ", "img_caption": "AstraZeneca | LinkedIn"}, {"img_url": "https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fnrd.2017.244/MediaObjects/41573_2018_Article_BFnrd2017244_Fig1_HTML.jpg", "img_caption": "Impact of a five-dimensional framework on R&D productivity at AstraZeneca |  Nature Reviews Drug Discovery"}]}
{"catalog": "D:\\project\\AspectMMKG\\Entities\\AstraZeneca\\History\\2007–12  The patent cliff and subsequent acquisitions", "query": "AstraZeneca's pipeline", "images": [{"img_url": "https://static.seekingalpha.com/uploads/2014/8/4/23954973-14071314885336778-Amit-H--Shah_origin.png", "img_caption": "AstraZeneca Has 30% Upside As A Takeover Candidate (NASDAQ:AZN) | Seeking  Alpha"}, {"img_url": "https://www.statnews.com/wp-content/uploads/2021/09/AZ-Oncology-pipeline-wheel-14-Sept.png", "img_caption": "Stopping cancer in its tracks with new approaches in oncology - STAT"}, {"img_url": "https://static.seekingalpha.com/uploads/2022/5/2/51181085-16514981529900515_origin.png", "img_caption": "AstraZeneca Stock: Our Next Growth Pick (NASDAQ:AZN) | Seeking Alpha"}, {"img_url": "https://www.pharmalive.com/wp-content/uploads/2020/02/AstraZeneca-2020.jpg", "img_caption": "Top 10 Pipelines To Watch – PharmaLive"}, {"img_url": "https://www.rootsanalysis.com/blog/wp-content/uploads/2020/06/image-6-1024x554.png", "img_caption": "ASCO 2020: AstraZeneca Presents a Game-Changer in Lung Cancer | Blog Cancer"}]}
{"catalog": "D:\\project\\AspectMMKG\\Entities\\AstraZeneca\\History\\2007–12  The patent cliff and subsequent acquisitions", "query": "A few days later AstraZeneca acquired US company MedImmune for about US$15", "images": [{"img_url": "https://britishheritage.org/images/22/02/ru-6enzvtebbkr831.jpg", "img_caption": "AstraZeneca - A Big Pharma Company that is Ethical | British Heritage"}, {"img_url": "https://upload.wikimedia.org/wikipedia/commons/b/bf/AstraZeneca_HQ_in_Cambridge_UK.jpg", "img_caption": "AstraZeneca - Wikipedia"}, {"img_url": "https://upload.wikimedia.org/wikipedia/commons/thumb/2/2a/AstraZeneca_HQ_in_Cambridge_UK_under_construction_in_sunset.jpg/220px-AstraZeneca_HQ_in_Cambridge_UK_under_construction_in_sunset.jpg", "img_caption": "AstraZeneca - Wikipedia"}, {"img_url": "https://upload.wikimedia.org/wikipedia/commons/thumb/f/f0/Astrahassleentrance.JPG/220px-Astrahassleentrance.JPG", "img_caption": "AstraZeneca - Wikipedia"}, {"img_url": "https://britishheritage.org/images/22/02/ru-6enzvtebbkr831.jpg", "img_caption": "AstraZeneca - A Big Pharma Company that is Ethical | British Heritage"}]}
{"catalog": "D:\\project\\AspectMMKG\\Entities\\AstraZeneca\\History\\2007–12  The patent cliff and subsequent acquisitions", "query": "2 billion to gain flu vaccines and an anti-viral treatment for infants; AstraZeneca subsequently consolidated all of its biologics operations into a dedicated biologics division called MedImmune", "images": [{"img_url": "https://media.nature.com/lw800/magazine-assets/d43747-020-00801-1/d43747-020-00801-1_18271052.png", "img_caption": "Biopharmas targeting common viral denominators to battle flu"}, {"img_url": "https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12929-019-0592-z/MediaObjects/12929_2019_592_Fig1_HTML.png", "img_caption": "Development of therapeutic antibodies for the treatment of diseases |  Journal of Biomedical Science | Full Text"}, {"img_url": "https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12929-019-0592-z/MediaObjects/12929_2019_592_Fig5_HTML.png", "img_caption": "Development of therapeutic antibodies for the treatment of diseases |  Journal of Biomedical Science | Full Text"}, {"img_url": "https://www.mdpi.com/vaccines/vaccines-06-00019/article_deploy/html/images/vaccines-06-00019-g001-550.jpg", "img_caption": "Vaccines | Free Full-Text | Efforts to Improve the Seasonal Influenza  Vaccine | HTML"}, {"img_url": "https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fnrd4529/MediaObjects/41573_2015_Article_BFnrd4529_Fig1_HTML.jpg", "img_caption": "Advances in the development of influenza virus vaccines | Nature Reviews  Drug Discovery"}]}
{"catalog": "D:\\project\\AspectMMKG\\Entities\\AstraZeneca\\History\\2007–12  The patent cliff and subsequent acquisitions", "query": "AstraZeneca acquired Novexel Corp", "images": [{"img_url": "https://upload.wikimedia.org/wikipedia/commons/thumb/b/bf/AstraZeneca_HQ_in_Cambridge_UK.jpg/1200px-AstraZeneca_HQ_in_Cambridge_UK.jpg", "img_caption": "AstraZeneca - Wikipedia"}, {"img_url": "https://upload.wikimedia.org/wikipedia/commons/thumb/2/2a/AstraZeneca_HQ_in_Cambridge_UK_under_construction_in_sunset.jpg/220px-AstraZeneca_HQ_in_Cambridge_UK_under_construction_in_sunset.jpg", "img_caption": "AstraZeneca - Wikipedia"}, {"img_url": "https://atlasventure.com/wp-content/uploads/Novexel.png", "img_caption": "Novexel - Atlas Venture"}, {"img_url": "https://upload.wikimedia.org/wikipedia/commons/thumb/f/f0/Astrahassleentrance.JPG/220px-Astrahassleentrance.JPG", "img_caption": "AstraZeneca - Wikipedia"}, {"img_url": "https://assets-delawarebusinesstimes-com.s3-accelerate.amazonaws.com/2021/09/AstraZeneca-web.jpg", "img_caption": "AstraZeneca acquires Caelum Biosciences for $150M - DBT"}]}
{"catalog": "D:\\project\\AspectMMKG\\Entities\\AstraZeneca\\History\\2007–12  The patent cliff and subsequent acquisitions", "query": "AstraZeneca acquired Guangdong BeiKang Pharmaceutical Company", "images": [{"img_url": "https://www.asianscientist.com/wp-content/uploads/bfi_thumb/AstraZeneca-Acquires-Chinese-Generics-Maker-Guangdong-BeiKang-Pharma1-2r0jz6d8w5mw9wvv90piww.jpg", "img_caption": "AstraZeneca Acquires Chinese Generics Maker, Guangdong BeiKang Pharma -  Asian Scientist Magazine"}, {"img_url": "https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2017/09/3l-image-12.jpg", "img_caption": "AstraZeneca's New Manufacturing Facility, Taizhou - Pharmaceutical  Technology"}, {"img_url": "https://upload.wikimedia.org/wikipedia/commons/thumb/b/bf/AstraZeneca_HQ_in_Cambridge_UK.jpg/1200px-AstraZeneca_HQ_in_Cambridge_UK.jpg", "img_caption": "AstraZeneca - Wikipedia"}, {"img_url": "https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2017/09/1l-image-12.jpg", "img_caption": "AstraZeneca's New Manufacturing Facility, Taizhou - Pharmaceutical  Technology"}, {"img_url": "https://upload.wikimedia.org/wikipedia/commons/thumb/2/2a/AstraZeneca_HQ_in_Cambridge_UK_under_construction_in_sunset.jpg/220px-AstraZeneca_HQ_in_Cambridge_UK_under_construction_in_sunset.jpg", "img_caption": "AstraZeneca - Wikipedia"}]}
{"catalog": "D:\\project\\AspectMMKG\\Entities\\AstraZeneca\\History\\2007–12  The patent cliff and subsequent acquisitions", "query": "AstraZeneca and Amgen announced a collaboration on treatments for inflammatory diseases", "images": [{"img_url": "https://mma.prnewswire.com/media/152881/amgen_logo.jpg?w=500", "img_caption": "Amgen Announces Tezepelumab Biologics License Application Submitted To U.S.  FDA"}, {"img_url": "https://www.toacorn.com/wp-content/uploads/images/2021-12-23/43p1.jpg", "img_caption": "Big finish: Amgen receives two FDA approvals in two days"}, {"img_url": "https://www.worldpharmatoday.com/wp-content/uploads/2017/07/images_article_pressrelease_amgen_array_biopharma.jpg", "img_caption": "Amgen And Array BioPharma Announce Preclinical License And Collaboration  Agreement In Inflammation | World Pharma Today"}, {"img_url": "https://qtxasset.com/cdn-cgi/image/w=384,h=216,f=auto,fit=crop,g=0.5x0.5/https://qtxasset.com/quartz/qcloud5/media/image/fiercebiotech/1605003445/PurpleLung.PNG/PurpleLung.PNG?VersionId=Kjn82OcPqErXZ2FSLE_vz23cCWMebFP0", "img_caption": "Amgen, AstraZeneca's tezepelumab hits goal in asthma phase 3 | Fierce  Biotech"}, {"img_url": "https://vertassets.blob.core.windows.net/image/dc051dfb/dc051dfb-a330-4896-9f92-172d8ccf7fcf/375_250-pills_out_of_bottle_450x300.jpg", "img_caption": "FDA News Roundup Teva AstraZeneca Amgen Medicines Company And More"}]}
{"catalog": "D:\\project\\AspectMMKG\\Entities\\AstraZeneca\\History\\2007–12  The patent cliff and subsequent acquisitions", "query": "AstraZeneca acquired Ardea Biosciences", "images": [{"img_url": "https://assets.bizclikmedia.net/1336/767ef1172421733f0df20881ef9ef3bc:d936473815a1e37b841c2fcb1f63ae7a/article-im112-astrazeneca-headquarters-jpeg.webp", "img_caption": "AstraZeneca buys Ardea Biosciences for $1.26 billion | Healthcare Digital"}, {"img_url": "https://res.cloudinary.com/crunchbase-production/image/upload/c_lpad,f_auto,q_auto:eco,dpr_1/v1448253939/lxkplfqnmjtxuczkhvfv.png", "img_caption": "Ardea Biosciences - Crunchbase Company Profile & Funding"}, {"img_url": "https://res.cloudinary.com/crunchbase-production/image/upload/c_lpad,h_256,w_256,f_auto,q_auto:eco,dpr_1/v1448253939/lxkplfqnmjtxuczkhvfv.png", "img_caption": "Ardea Biosciences - Crunchbase Company Profile & Funding"}, {"img_url": "https://image.pitchbook.com/HcSRE7aveCFDau7k455pHV4Ws451605406789400_200x200", "img_caption": "Ardea Biosciences Company Profile: Acquisition & Investors | PitchBook"}, {"img_url": "https://i.dailymail.co.uk/i/pix/2012/04/23/article-0-12BBBDB6000005DC-682_468x335.jpg", "img_caption": "AstraZeneca is set to swallow up US pharma rival Ardea Biosciences | This  is Money"}]}
{"catalog": "D:\\project\\AspectMMKG\\Entities\\AstraZeneca\\History\\2007–12  The patent cliff and subsequent acquisitions", "query": "AstraZeneca and Bristol Myers Squibb announced a two-stage deal for the joint acquisition of the biotechnology company Amylin Pharmaceuticals", "images": [{"img_url": "https://diatribe.org/sites/default/files/Bydureon_0_0.jpg", "img_caption": "Bristol-Myers Squibb and AstraZeneca Purchase Amylin"}, {"img_url": "https://upload.wikimedia.org/wikipedia/commons/thumb/b/b9/Amylin_Pharmaceuticals.svg/1200px-Amylin_Pharmaceuticals.svg.png", "img_caption": "Amylin Pharmaceuticals - Wikipedia"}, {"img_url": "https://upload.wikimedia.org/wikipedia/commons/thumb/b/bf/AstraZeneca_HQ_in_Cambridge_UK.jpg/1200px-AstraZeneca_HQ_in_Cambridge_UK.jpg", "img_caption": "AstraZeneca - Wikipedia"}, {"img_url": "https://static.reuters.com/resources/r/?m=02&d=20120702&t=2&i=625728613&r=CBRE8611JEO00&w=800", "img_caption": "Bristol's patent woes persist despite Amylin buy | Reuters"}, {"img_url": "https://static.cambridge.org/binary/version/id/urn:cambridge.org:id:binary:20200205101657899-0137:9781108785549:47944fig3_50.png?pub-status=live", "img_caption": "The Biotechnology Sector: Therapeutics (Chapter 3) - The Business of  Healthcare Innovation"}]}
{"catalog": "D:\\project\\AspectMMKG\\Entities\\AstraZeneca\\History\\2007–12  The patent cliff and subsequent acquisitions", "query": "with AstraZeneca then paying $3", "images": [{"img_url": "https://ca-times.brightspotcdn.com/dims4/default/e313855/2147483647/strip/true/crop/3500x2310+0+0/resize/1486x981!/quality/90/?url=https%3A%2F%2Fcalifornia-times-brightspot.s3.amazonaws.com%2F85%2F8c%2F580ff12eea88418221134dc22e4f%2F35a95c426bd64a57aa3fbb386d925316", "img_caption": "Africa will pay more for Russian COVID vaccine than for Oxford-AstraZeneca,  Novavax shots"}, {"img_url": "https://i.insider.com/5f71dadb74fe5b0018a8db55?width=750&format=jpeg&auto=webp", "img_caption": "Why Oxford COVID-19 Vaccine Is Cheaper Than Pfizer, Moderna Jabs"}, {"img_url": "https://qtxasset.com/cdn-cgi/image/w=384,h=216,f=auto,fit=crop,g=0.5x0.5/https://qtxasset.com/quartz/qcloud5/media/image/2016-07/Tagrisso.jpg?VersionId=rZEmjzu6yigapWEDVBIbT0hSL1ocX6Ak", "img_caption": "AstraZeneca's Tagrisso, aiming for $3B in sales, trounces chemo in new  phase 3 trial | Fierce Pharma"}, {"img_url": "https://cloudfront-us-east-2.images.arcpublishing.com/reuters/67LAYZ7O5BNPBGP3QXYIINET3E.jpg", "img_caption": "South Africa to pay $5.25 a dose for AstraZeneca vaccine from India's SII |  Reuters"}, {"img_url": "https://img.etimg.com/thumb/msid-80386036,width-300,imgsize-835424,,resizemode-4,quality-100/titled-design-2020-12-12t191310-075.jpg", "img_caption": "astrazeneca vaccine: South Africa to pay $5.25 a dose for AstraZeneca  vaccine from India's Serum Institute - The Economic Times"}]}
{"catalog": "D:\\project\\AspectMMKG\\Entities\\AstraZeneca\\History\\2007–12  The patent cliff and subsequent acquisitions", "query": "and Amylin being folded into an existing diabetes joint venture between AstraZeneca and Bristol Myers Squibb", "images": [{"img_url": "https://diatribe.org/sites/default/files/styles/articles_full_content_main_/public/Bydureon_0_0.jpg?itok=G-rTtztr", "img_caption": "Bristol-Myers Squibb and AstraZeneca Purchase Amylin"}, {"img_url": "https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/44ac0b9d-e78c-4651-99ff-dccd21a5ff54/gr1.jpg", "img_caption": "Diabetes and Cancer—An AACE/ACE Consensus Statement - Endocrine Practice"}, {"img_url": "https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/aa4c9801-55df-40b0-9e07-0a885bc3d04c/gr1.jpg", "img_caption": "American Association Of Clinical Endocrinologists And American College Of  Endocrinology -Clinical Practice Guidelines For Developing A Diabetes  Mellitus Comprehensive Care Plan – 2015 - Endocrine Practice"}, {"img_url": "https://www.pmlive.com/__data/assets/image/0016/450205/astrazeneca-BMS.jpg", "img_caption": "AstraZeneca buys BMS out of diabetes alliance - PMLiVE"}, {"img_url": "https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/acb74c8c-0007-4568-aa18-a3a041f8b8d3/gr1.jpg", "img_caption": "American Association of Clinical Endocrinologists Medical Guidelines for  Clinical Practice for Developing a Diabetes Mellitus Comprehensive Care  Plan - Endocrine Practice"}]}
{"catalog": "D:\\project\\AspectMMKG\\Entities\\AstraZeneca\\History\\2013 restructuring and beyond", "query": "Entities\\AstraZeneca 2013 restructuring and beyond", "images": [{"img_url": "https://www2.deloitte.com/content/dam/insights/us/articles/6933_HC_Trends-diving-deeper/images/6933_Banner_DivingDeeper.jpg/_jcr_content/renditions/cq5dam.web.1440.660.jpeg", "img_caption": "Back Button"}, {"img_url": "https://upload.wikimedia.org/wikipedia/commons/thumb/2/2a/AstraZeneca_HQ_in_Cambridge_UK_under_construction_in_sunset.jpg/220px-AstraZeneca_HQ_in_Cambridge_UK_under_construction_in_sunset.jpg", "img_caption": "AstraZeneca - Wikipedia"}, {"img_url": "https://www2.deloitte.com/content/dam/insights/us/articles/6933_HC_Trends-diving-deeper/figures/6933_Figure7.jpg", "img_caption": "Back Button"}, {"img_url": "https://binary.pensoft.net/fig/623404/singlefig", "img_caption": "Biodiversity Community Integrated Knowledge Library (BiCIKL)"}, {"img_url": "https://qtxasset.com/quartz/qcloud5/media/image/2016-05/aznhq1.jpg?VersionId=kOkE_J2abK_IYPqp_4yVYRJfbIbz4fSM", "img_caption": "AstraZeneca to 'reshape' manufacturing as part of $1.5B cost-cutting effort  | Fierce Pharma"}]}
{"catalog": "D:\\project\\AspectMMKG\\Entities\\AstraZeneca\\History\\2013 restructuring and beyond\\2013", "query": "Entities\\AstraZeneca 2013", "images": [{"img_url": "https://www.science.org/cms/10.1126/scitranslmed.aaa3679/asset/54b56636-7075-4f2c-b4b8-acef53abe225/assets/graphic/7286ps12_f1.jpeg", "img_caption": "How to handle an industry in disruption: Intervene or laissez-faire?"}, {"img_url": "https://cdn.sanity.io/images/0vv8moc6/pharmtech/6fde0500147bfc70e76130b11742d7a730ec5b6d-250x188.jpg", "img_caption": "Tracking Innovation in New Molecular Entities of 2013"}, {"img_url": "https://www.reuters.com/resizer/jIDLu9k5yk8Agc7Vy0BJ_WWuveE=/1920x1920/smart/filters:quality(80)/cloudfront-us-east-2.images.arcpublishing.com/reuters/BKMAHJFOHNNU5IIVN5BSDS7GPU.jpg", "img_caption": "Britain's Prince Charles opens new AstraZeneca research centre | Reuters"}, {"img_url": "https://www.statnews.com/wp-content/uploads/2016/04/AP_090129060159-1024x576.jpg", "img_caption": "AstraZeneca to pay $5.5 million for bribing doctors in China and Russia"}, {"img_url": "https://www.followthemoney.org/assets/press/Blog-Images-Money-Tale/PfizerAstraZ/PfizerAstraZGivingPatterns-2000-13.png", "img_caption": "Take Two (or 30 Million) and Call Us in the Morning: Pfizer and  AstraZeneca's 2000-2013 State Campaign Contributions - FollowTheMoney.org"}]}
{"catalog": "D:\\project\\AspectMMKG\\Entities\\AstraZeneca\\History\\2013 restructuring and beyond\\2013", "query": "In March 2013 AstraZeneca announced plans for a major corporate restructuring", "images": [{"img_url": "https://d2cbg94ubxgsnp.cloudfront.net/Pictures/480xAny/4/5/5/85455_plots-secured-by-astrazeneca-and-medimmune-on-the-cambridge-biomedical-campus_630.jpg", "img_caption": "AstraZeneca announces new UK hub | Business | Chemistry World"}, {"img_url": "https://qtxasset.com/cdn-cgi/image/w=384,h=216,f=auto,fit=crop,g=0.5x0.5/https://qtxasset.com/quartz/qcloud5/media/image/fiercebiotech/1516966355/CGI%20aerial_view.jpg/CGI%20aerial_view.jpg?VersionId=NtveTbrH6ZzljaHJz.2Mtx_bs4e_Aj_6", "img_caption": "AstraZeneca's triple-hit COPD inhaler meets goals in phase 3, setting up  scrap with GlaxoSmithKline | Fierce Biotech"}, {"img_url": "https://upload.wikimedia.org/wikipedia/commons/thumb/2/2a/AstraZeneca_HQ_in_Cambridge_UK_under_construction_in_sunset.jpg/220px-AstraZeneca_HQ_in_Cambridge_UK_under_construction_in_sunset.jpg", "img_caption": "AstraZeneca - Wikipedia"}, {"img_url": "https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fnbt0613-476/MediaObjects/41587_2013_Article_BFnbt0613476_Figa_HTML.jpg", "img_caption": "AstraZeneca juggernaut heads for Cambridge | Nature Biotechnology"}, {"img_url": "https://qtxasset.com/cdn-cgi/image/w=384,h=216,f=auto,fit=crop,g=0.5x0.5/https://qtxasset.com/quartz/qcloud5/media/image/fiercebiotech/1527100404/astellas.jpg/astellas.jpg?VersionId=86juEHIDBItIKJ_2_x5RBSEg0Erbddl2", "img_caption": "Astellas to halt work at R&D subsidiary amid restructuring plan | Fierce  Biotech"}]}
{"catalog": "D:\\project\\AspectMMKG\\Entities\\AstraZeneca\\History\\2013 restructuring and beyond\\2013", "query": "AstraZeneca also announced that it would move its corporate headquarters from London to Cambridge in 2016", "images": [{"img_url": "https://upload.wikimedia.org/wikipedia/commons/thumb/b/bf/AstraZeneca_HQ_in_Cambridge_UK.jpg/1200px-AstraZeneca_HQ_in_Cambridge_UK.jpg", "img_caption": "AstraZeneca - Wikipedia"}, {"img_url": "https://www.architecturalrecord.com/ext/resources/news/2021/November/AstraZeneca/AstraZeneca-1.jpg?t=1638144366&width=900", "img_caption": "AstraZeneca Unveils a New Headquarters in Cambridge | 2021-11-28 |  Architectural Record"}, {"img_url": "https://www.architecturalrecord.com/ext/resources/news/2021/November/AstraZeneca/AstraZeneca-4.jpg?t=1638200634&width=900", "img_caption": "AstraZeneca Unveils a New Headquarters in Cambridge | 2021-11-28 |  Architectural Record"}, {"img_url": "https://www.timeshighereducation.com/sites/default/files/styles/the_breaking_news_image_style/public/Pictures/web/b/i/a/colourful_selection_of_pills.jpg?itok=NoGAFaG3", "img_caption": "AstraZeneca cuts UK headcount and moves to Cambridge | Times Higher  Education (THE)"}, {"img_url": "https://darkroom.ribaj.com/1200/138b3f436fae02498ccda420928b6acb:7e4c7c90e6d3333c7d87d26feb0693ed/astrazeneca-s-new-discovery-centre-by-herzog-de-meuron-at-cambridge-biomedical-campus", "img_caption": "Herzog & de Meuron's AstraZeneca HQ opens at last and architecture  regulation debate | RIBAJ"}]}
{"catalog": "D:\\project\\AspectMMKG\\Entities\\AstraZeneca\\History\\2013 restructuring and beyond\\2013", "query": "AstraZeneca announced it would acquire biotech oncology company Spirogen for around US$440 million", "images": [{"img_url": "https://britishheritage.org/images/22/02/ru-6enzvtebbkr831.jpg", "img_caption": "AstraZeneca - A Big Pharma Company that is Ethical | British Heritage"}, {"img_url": "https://ars.els-cdn.com/content/image/1-s2.0-S1359644614004139-gr1.jpg", "img_caption": "Racing to define pharmaceutical R&D external innovation models -  ScienceDirect"}, {"img_url": "https://ars.els-cdn.com/content/image/1-s2.0-S1359644614004139-gr3.jpg", "img_caption": "Racing to define pharmaceutical R&D external innovation models -  ScienceDirect"}, {"img_url": "https://ars.els-cdn.com/content/image/1-s2.0-S1359644614004139-gr4.jpg", "img_caption": "Racing to define pharmaceutical R&D external innovation models -  ScienceDirect"}, {"img_url": "https://britishheritage.org/images/22/02/ru-3enzvtebbkr206_t.jpg", "img_caption": "AstraZeneca - A Big Pharma Company that is Ethical | British Heritage"}]}
{"catalog": "D:\\project\\AspectMMKG\\Entities\\AstraZeneca\\History\\2013 restructuring and beyond\\2014", "query": "Entities\\AstraZeneca 2014", "images": [{"img_url": "https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fnrd4309/MediaObjects/41573_2014_Article_BFnrd4309_Fig1_HTML.jpg", "img_caption": "Lessons learned from the fate of AstraZeneca's drug pipeline: a  five-dimensional framework | Nature Reviews Drug Discovery"}, {"img_url": "https://www.science.org/cms/10.1126/scitranslmed.aaa3679/asset/54b56636-7075-4f2c-b4b8-acef53abe225/assets/graphic/7286ps12_f1.jpeg", "img_caption": "How to handle an industry in disruption: Intervene or laissez-faire?"}, {"img_url": "https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fnrd4309/MediaObjects/41573_2014_Article_BFnrd4309_Fig4_HTML.jpg", "img_caption": "Lessons learned from the fate of AstraZeneca's drug pipeline: a  five-dimensional framework | Nature Reviews Drug Discovery"}, {"img_url": "https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fnrd4309/MediaObjects/41573_2014_Article_BFnrd4309_Fig2_HTML.jpg", "img_caption": "Lessons learned from the fate of AstraZeneca's drug pipeline: a  five-dimensional framework | Nature Reviews Drug Discovery"}, {"img_url": "https://i.guim.co.uk/img/static/sys-images/Guardian/Pix/audio/video/2014/5/13/1399977945386/AstraZeneca-drugs--014.jpg?width=1200&height=630&quality=85&auto=format&fit=crop&overlay-align=bottom%2Cleft&overlay-width=100p&overlay-base64=L2ltZy9zdGF0aWMvb3ZlcmxheXMvdGctYWdlLTIwMTQucG5n&enable=upscale&s=d935e1a9e41927d87dd08a70fa039066", "img_caption": "AstraZeneca rejects Pfizer's final £69bn takeover bid | AstraZeneca | The  Guardian"}]}
{"catalog": "D:\\project\\AspectMMKG\\Entities\\AstraZeneca\\History\\2013 restructuring and beyond\\2014", "query": "On 19 May 2014 AstraZeneca rejected a \"final offer\" from Pfizer of £55 per share", "images": [{"img_url": "https://fournews-assets-prod-s3-ew1-nmprod.s3.amazonaws.com/media/2014/05/19_astra_g_w.jpg", "img_caption": "AstraZeneca rejects Pfizer's 'final' offer – Channel 4 News"}, {"img_url": "https://i.guim.co.uk/img/static/sys-images/Guardian/Pix/audio/video/2014/5/13/1399977945386/AstraZeneca-drugs--014.jpg?width=620&quality=85&fit=max&s=0811c3d44a1f935ab3698d84b1f534e3", "img_caption": "AstraZeneca rejects Pfizer's final £69bn takeover bid | AstraZeneca | The  Guardian"}, {"img_url": "https://image.cnbcfm.com/api/v1/image/101675677-488548277.jpg?v=1400156001", "img_caption": "AstraZeneca board rejects Pfizer's 'final' proposal"}, {"img_url": "https://i2.cdn.turner.com/money/dam/assets/140518212718-pfizer-640x360.jpg", "img_caption": "AstraZeneca rejects 'final' offer from Pfizer"}, {"img_url": "https://ichef.bbci.co.uk/news/464/mcs/media/images/74954000/jpg/_74954373_dpkjmifw.jpg", "img_caption": "AstraZeneca rejects 'final' takeover bid from Pfizer - BBC News"}]}
{"catalog": "D:\\project\\AspectMMKG\\Entities\\AstraZeneca\\History\\2013 restructuring and beyond\\2014", "query": "one of AstraZeneca's three target therapeutic areas announced the year before", "images": [{"img_url": "https://qtxasset.com/quartz/qcloud5/media/image/ULTOMIRIS%202.jpg?VersionId=PBIuAle2Zbb8zy3qYXMgk2vxAYxOBvBY", "img_caption": "AAN: AstraZeneca touts new Ultomiris gMG data ahead of potential Argenx  showdown | Fierce Pharma"}, {"img_url": "https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1644524563/GettyImages-1288838574.jpg/GettyImages-1288838574.jpg?VersionId=jMg8iPpcnuQy.Vl4ESzWW25xXQszjp7i", "img_caption": "AstraZeneca's COVID vaccine sales reached $4B last year, but don't expect  that much in 2022 | Fierce Pharma"}, {"img_url": "https://www.ddw-online.com/media/32/2-table1.jpg", "img_caption": "Astrazeneca R&D - Improving Drug Development Productivity With Better  Predictivity - Drug Discovery World (DDW)"}, {"img_url": "https://qtxasset.com/quartz/qcloud5/styles/half_body_width/s3/media/image/growthq1.png?VersionId=0QEojKEUzh.mda2.6JgSoPzK7gK_dRD9&itok=YYOud3K1", "img_caption": "Pfizer, Merck, AstraZeneca lead Big Pharma growth in Q1"}, {"img_url": "https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2022/07/Figure-1-1.jpg", "img_caption": "AstraZeneca acquires TeneoTwo in $1.3bn deal to broaden haematology  portfolio - Pharmaceutical Technology"}]}
{"catalog": "D:\\project\\AspectMMKG\\Entities\\AstraZeneca\\History\\2013 restructuring and beyond\\2015", "query": "Entities\\AstraZeneca 2015", "images": [{"img_url": "https://www.reuters.com/resizer/wEp0IIq93I0hDbX6CcQORUtzZ58=/1920x1005/smart/filters:quality(80)/cloudfront-us-east-2.images.arcpublishing.com/reuters/5OC7QDE6GJPEDKI7TVPDPLZ2LI.jpg", "img_caption": "AstraZeneca lifts revenue guidance on COVID treatment | Reuters"}, {"img_url": "https://media.nature.com/lw800/magazine-assets/d41573-019-00014-x/d41573-019-00014-x_16398106.jpg", "img_caption": "2018 FDA drug approvals"}, {"img_url": "https://gh.bmj.com/content/bmjgh/6/12/e007321/F5.large.jpg", "img_caption": "Who funded the research behind the Oxford–AstraZeneca COVID-19 vaccine? |  BMJ Global Health"}, {"img_url": "https://gh.bmj.com/content/bmjgh/6/12/e007321/F1.large.jpg", "img_caption": "Who funded the research behind the Oxford–AstraZeneca COVID-19 vaccine? |  BMJ Global Health"}, {"img_url": "https://www.reuters.com/resizer/rG2g_UEwA3bxUaZpmfZ7lXNkrps=/960x1200/smart/filters:quality(80)/cloudfront-us-east-2.images.arcpublishing.com/reuters/5OC7QDE6GJPEDKI7TVPDPLZ2LI.jpg", "img_caption": "AstraZeneca lifts revenue guidance on COVID treatment | Reuters"}]}
{"catalog": "D:\\project\\AspectMMKG\\Entities\\AstraZeneca\\History\\2013 restructuring and beyond\\2015", "query": "and multiple myeloma with AstraZeneca receiving US$450 million", "images": [{"img_url": "https://britishheritage.org/images/22/02/ru-6enzvtebbkr831.jpg", "img_caption": "AstraZeneca - A Big Pharma Company that is Ethical | British Heritage"}, {"img_url": "https://britishheritage.org/images/22/02/ru-1enzvtebbkr243_t.png", "img_caption": "AstraZeneca - A Big Pharma Company that is Ethical | British Heritage"}, {"img_url": "https://upload.wikimedia.org/wikipedia/commons/b/bf/AstraZeneca_HQ_in_Cambridge_UK.jpg", "img_caption": "AstraZeneca - Wikipedia"}, {"img_url": "https://upload.wikimedia.org/wikipedia/commons/thumb/2/2a/AstraZeneca_HQ_in_Cambridge_UK_under_construction_in_sunset.jpg/220px-AstraZeneca_HQ_in_Cambridge_UK_under_construction_in_sunset.jpg", "img_caption": "AstraZeneca - Wikipedia"}, {"img_url": "https://upload.wikimedia.org/wikipedia/commons/thumb/f/f0/Astrahassleentrance.JPG/220px-Astrahassleentrance.JPG", "img_caption": "AstraZeneca - Wikipedia"}]}
{"catalog": "D:\\project\\AspectMMKG\\Entities\\AstraZeneca\\History\\2013 restructuring and beyond\\2015", "query": "Genzyme announced it would acquire the rare cancer drug Caprelsa (vandetanib) from AstraZeneca for up to US$300 million", "images": [{"img_url": "https://britishheritage.org/images/22/03/tu-5enzmzpennm387_t.jpg", "img_caption": "AstraZeneca - A Big Pharma Company that is Ethical | British Heritage"}, {"img_url": "https://britishheritage.org/images/22/02/ru-6enzvtebbkr831_t.jpg", "img_caption": "AstraZeneca - A Big Pharma Company that is Ethical | British Heritage"}, {"img_url": "https://britishheritage.org/images/22/02/ru-1enzvtebbkr243_t.png", "img_caption": "AstraZeneca - A Big Pharma Company that is Ethical | British Heritage"}, {"img_url": "https://britishheritage.org/images/22/02/ru-3enzvtebbkr206_t.jpg", "img_caption": "AstraZeneca - A Big Pharma Company that is Ethical | British Heritage"}, {"img_url": "https://upload.wikimedia.org/wikipedia/en/thumb/4/4f/AstraZeneca.svg/440px-AstraZeneca.svg.png", "img_caption": "AstraZeneca - Wikiwand"}]}
{"catalog": "D:\\project\\AspectMMKG\\Entities\\AstraZeneca\\History\\2013 restructuring and beyond\\2015", "query": "On 6 November it was reported that AstraZeneca had acquired ZS Pharma for US$2", "images": [{"img_url": "https://i1.rgstatic.net/publication/360492354_Cancer_in_sub-Saharan_Africa_a_Lancet_Oncology_Commission/links/6281447a37329433d9b3de0c/largepreview.png", "img_caption": "PDF) Cancer in sub-Saharan Africa: a Lancet Oncology Commission"}, {"img_url": "https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/aca64838-2c24-491e-86c3-eebf3b65fc70/gr2_lrg.jpg", "img_caption": "References in Future cancer research priorities in the USA: a Lancet  Oncology Commission - The Lancet Oncology"}, {"img_url": "https://i1.rgstatic.net/publication/360492354_Cancer_in_sub-Saharan_Africa_a_Lancet_Oncology_Commission/links/6281447a37329433d9b3de0c/largepreview.png", "img_caption": "PDF) Cancer in sub-Saharan Africa: a Lancet Oncology Commission"}, {"img_url": "https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/aca64838-2c24-491e-86c3-eebf3b65fc70/gr2_lrg.jpg", "img_caption": "References in Future cancer research priorities in the USA: a Lancet  Oncology Commission - The Lancet Oncology"}, {"img_url": "https://i1.rgstatic.net/publication/360492354_Cancer_in_sub-Saharan_Africa_a_Lancet_Oncology_Commission/links/6281447a37329433d9b3de0c/largepreview.png", "img_caption": "PDF) Cancer in sub-Saharan Africa: a Lancet Oncology Commission"}]}
{"catalog": "D:\\project\\AspectMMKG\\Entities\\AstraZeneca\\History\\2013 restructuring and beyond\\2017", "query": "Entities\\AstraZeneca 2017", "images": [{"img_url": "https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fnrd.2017.244/MediaObjects/41573_2018_Article_BFnrd2017244_Fig1_HTML.jpg", "img_caption": "Impact of a five-dimensional framework on R&D productivity at AstraZeneca |  Nature Reviews Drug Discovery"}, {"img_url": "https://pbs.twimg.com/media/DhWf-l8UwAAt76a.jpg:large", "img_caption": "AstraZeneca on Twitter: \"2017 was a significant year for our IMED Biotech  Unit. We continued to drive R&D productivity with the aim to deliver  #lifechanging #medicines to patients. Read more here:  https://t.co/UBFlcVEHo5"}, {"img_url": "https://media.nature.com/lw800/magazine-assets/d41573-019-00014-x/d41573-019-00014-x_16398106.jpg", "img_caption": "2018 FDA drug approvals"}, {"img_url": "https://khn.org/wp-content/uploads/sites/2/2020/08/GettyImages-1227715002.jpg", "img_caption": "They Pledged to Donate Rights to Their COVID Vaccine, Then Sold Them to  Pharma | Kaiser Health News"}, {"img_url": "https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fnrd.2017.244/MediaObjects/41573_2018_Article_BFnrd2017244_Fig6_HTML.jpg", "img_caption": "Impact of a five-dimensional framework on R&D productivity at AstraZeneca |  Nature Reviews Drug Discovery"}]}
{"catalog": "D:\\project\\AspectMMKG\\Entities\\AstraZeneca\\History\\2013 restructuring and beyond\\2017", "query": "In January EVP Pam Cheng stated that AstraZeneca has ignited startup of duplicate QA testing facility in Sweden and has initiated hiring in Sweden", "images": [{"img_url": "https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1604320437/Blue%20Coronavirus.jpg?VersionId=StJa5f0ljFk1_Tdok8kmrazFA0cAbtaY", "img_caption": "COVID-19 tracker: Pfizer, Moderna vaccines sharply cut hospitalizations in  older adults, CDC data show | Fierce Pharma"}, {"img_url": "https://pbs.twimg.com/ext_tw_video_thumb/1353682548522692608/pu/img/6oDtu2b1r3BLsc8a.jpg", "img_caption": "COVID-19 tracker: Pfizer, Moderna vaccines sharply cut hospitalizations in  older adults, CDC data show | Fierce Pharma"}, {"img_url": "https://pbs.twimg.com/media/EttxqnOXUAAEawP?format=png&name=small", "img_caption": "COVID-19 tracker: Pfizer, Moderna vaccines sharply cut hospitalizations in  older adults, CDC data show | Fierce Pharma"}, {"img_url": "https://pbs.twimg.com/media/EttxpmDXYAEAqoq?format=jpg&name=360x360", "img_caption": "COVID-19 tracker: Pfizer, Moderna vaccines sharply cut hospitalizations in  older adults, CDC data show | Fierce Pharma"}, {"img_url": "https://pbs.twimg.com/card_img/1550804905174122497/_CYMYyT2?format=jpg&name=small", "img_caption": "COVID-19 tracker: Pfizer, Moderna vaccines sharply cut hospitalizations in  older adults, CDC data show | Fierce Pharma"}]}
{"catalog": "D:\\project\\AspectMMKG\\Entities\\AstraZeneca\\History\\2013 restructuring and beyond\\2018", "query": "Entities\\AstraZeneca 2018", "images": [{"img_url": "https://media.nature.com/lw800/magazine-assets/d41573-019-00014-x/d41573-019-00014-x_16398106.jpg", "img_caption": "2018 FDA drug approvals"}, {"img_url": "https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fnrd.2017.244/MediaObjects/41573_2018_Article_BFnrd2017244_Fig1_HTML.jpg", "img_caption": "Impact of a five-dimensional framework on R&D productivity at AstraZeneca |  Nature Reviews Drug Discovery"}, {"img_url": "https://imageio.forbes.com/specials-images/imageserve/625229dcd0e9913af414a316/Total-New-Medical-Entities-by-Pharma-Company-1999-2018/960x0.jpg?height=324&width=711&fit=bounds", "img_caption": "What Are The Most Productive Pharmaceutical Companies?Pharmaceutical R&D  Efficiency Review 1999-2018"}, {"img_url": "https://gh.bmj.com/content/bmjgh/6/12/e007321/F1.large.jpg", "img_caption": "Who funded the research behind the Oxford–AstraZeneca COVID-19 vaccine? |  BMJ Global Health"}, {"img_url": "https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fnrd.2017.244/MediaObjects/41573_2018_Article_BFnrd2017244_Fig6_HTML.jpg", "img_caption": "Impact of a five-dimensional framework on R&D productivity at AstraZeneca |  Nature Reviews Drug Discovery"}]}
{"catalog": "D:\\project\\AspectMMKG\\Entities\\AstraZeneca\\History\\2013 restructuring and beyond\\2018", "query": "AstraZeneca announced it was spinning off six early-stage experimental drugs into a new biotechnology company", "images": [{"img_url": "https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1644524563/GettyImages-1288838574.jpg/GettyImages-1288838574.jpg?VersionId=jMg8iPpcnuQy.Vl4ESzWW25xXQszjp7i", "img_caption": "AstraZeneca's COVID vaccine sales reached $4B last year, but don't expect  that much in 2022 | Fierce Pharma"}, {"img_url": "https://static.reuters.com/resources/r/?m=02&d=20180228&t=2&i=1235890542&r=LYNXNPEE1R0GI&w=800", "img_caption": "AstraZeneca spins off autoimmune drugs into new biotech company | Reuters"}, {"img_url": "https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1604320437/Blue%20Coronavirus.jpg?VersionId=StJa5f0ljFk1_Tdok8kmrazFA0cAbtaY", "img_caption": "COVID-19 tracker: Pfizer, Moderna vaccines sharply cut hospitalizations in  older adults, CDC data show | Fierce Pharma"}, {"img_url": "https://qtxasset.com/cdn-cgi/image/w=384,h=216,f=auto,fit=crop,g=0.5x0.5/https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1592233896/5204602349_c87b204860_b.jpg/5204602349_c87b204860_b.jpg?VersionId=6mxYQ2ol4bPNyq4KK36coLrdW_SYgkMP", "img_caption": "AstraZeneca spinoff Viela Bio scored its first FDA nod. Can it face down  heavyweight rivals? | Fierce Pharma"}, {"img_url": "https://static01.nyt.com/images/2020/09/18/us/coronavirus-vaccine-tracker-promo-1600439734668/coronavirus-vaccine-tracker-promo-1600439734668-facebookJumbo-v183.png", "img_caption": "Covid-19 Vaccine Tracker: Latest Updates - The New York Times"}]}
{"catalog": "D:\\project\\AspectMMKG\\Entities\\AstraZeneca\\History\\2013 restructuring and beyond\\2019", "query": "Entities\\AstraZeneca 2019", "images": [{"img_url": "https://vertassets.blob.core.windows.net/image/bf1cf25e/bf1cf25e-23e8-4921-80d0-434efc8960c7/pr7318.png", "img_caption": "AstraZeneca Partnership Gives Significant Boost To Sun Pharma's Overall  China Entry Strategy, Says GlobalData"}, {"img_url": "https://news.microsoft.com/wp-content/uploads/prod/sites/93/2019/09/ai-factory-for-health-2-960x640.jpg", "img_caption": "Microsoft and AstraZeneca join forces on artificial intelligence for  healthcare - Microsoft News Centre Europe"}, {"img_url": "https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1628694126/GettyImages-1288838574.jpg/GettyImages-1288838574.jpg?VersionId=ak64CIs5nurK9.a3p74AD4NWUwuslNnK", "img_caption": "Facebook bans ad agency behind outlandish campaign deriding Pfizer,  AstraZeneca vaccines | Fierce Pharma"}, {"img_url": "https://www.bmj.com/content/bmj/371/bmj.m4750/F2.medium.jpg", "img_caption": "Reserving coronavirus disease 2019 vaccines for global access: cross  sectional analysis | The BMJ"}, {"img_url": "https://khn.org/wp-content/uploads/sites/2/2020/08/GettyImages-1227715002.jpg", "img_caption": "They Pledged to Donate Rights to Their COVID Vaccine, Then Sold Them to  Pharma | Kaiser Health News"}]}
{"catalog": "D:\\project\\AspectMMKG\\Entities\\AstraZeneca\\History\\2013 restructuring and beyond\\2019", "query": "AstraZeneca announced it will pay up to US$6", "images": [{"img_url": "https://d2v9ipibika81v.cloudfront.net/uploads/sites/32/us-aid-750.png", "img_caption": "What the United States Is Doing in Response to COVID-19 in Brazil - U.S.  Embassy & Consulates in Brazil"}, {"img_url": "https://www.bmj.com/content/bmj/371/bmj.m4750/F1.medium.jpg", "img_caption": "Reserving coronavirus disease 2019 vaccines for global access: cross  sectional analysis | The BMJ"}, {"img_url": "https://www.bmj.com/content/bmj/371/bmj.m4750/F3.large.jpg", "img_caption": "Reserving coronavirus disease 2019 vaccines for global access: cross  sectional analysis | The BMJ"}, {"img_url": "https://15pm7vnia02pnl8e1191kg1c-wpengine.netdna-ssl.com/wp-content/uploads/2020/11/how-vac-invest-graf.png", "img_caption": "How vaccines are reshaping portfolios - Nedbank Private Wealth"}, {"img_url": "https://www.bmj.com/content/bmj/371/bmj.m4750/F2.medium.jpg", "img_caption": "Reserving coronavirus disease 2019 vaccines for global access: cross  sectional analysis | The BMJ"}]}
{"catalog": "D:\\project\\AspectMMKG\\Entities\\AstraZeneca\\History\\2013 restructuring and beyond\\2019", "query": "AstraZeneca plans to use some of the proceeds of a US$3", "images": [{"img_url": "https://media.nature.com/lw800/magazine-assets/d41586-020-03370-6/d41586-020-03370-6_18641108.jpg", "img_caption": "How COVID vaccines are being divvied up around the world"}, {"img_url": "https://media.nature.com/lw1024/magazine-assets/d41586-020-03370-6/d41586-020-03370-6_18633110.jpg", "img_caption": "How COVID vaccines are being divvied up around the world"}, {"img_url": "https://images.theconversation.com/files/374158/original/file-20201210-13-1dbvyqi.jpg?ixlib=rb-1.1.0&rect=0%2C925%2C6000%2C3000&q=45&auto=format&w=1356&h=668&fit=crop", "img_caption": "Can a pharma company change? Profit, not altruism, motivates COVID-19  vaccine development"}, {"img_url": "https://media.nature.com/lw800/magazine-assets/d41586-020-03370-6/d41586-020-03370-6_18641106.jpg", "img_caption": "How COVID vaccines are being divvied up around the world"}, {"img_url": "https://upload.wikimedia.org/wikipedia/commons/thumb/d/dd/Oxford_AstraZeneca_COVID-19_vaccine_AZD1222_-_4.jpg/1200px-Oxford_AstraZeneca_COVID-19_vaccine_AZD1222_-_4.jpg", "img_caption": "Oxford–AstraZeneca COVID-19 vaccine - Wikipedia"}]}
{"catalog": "D:\\project\\AspectMMKG\\Entities\\AstraZeneca\\History\\2013 restructuring and beyond\\2019", "query": "AstraZeneca announced it would sell the global commercial rights for its drug to treat acid reflux to German pharmaceutical company Cheplapharm Arzneimittel GmbH for as much as US$276 million", "images": [{"img_url": "https://britishheritage.org/images/22/02/ru-6enzvtebbkr831.jpg", "img_caption": "AstraZeneca - A Big Pharma Company that is Ethical | British Heritage"}, {"img_url": "https://britishheritage.org/images/22/02/ru-3enzvtebbkr206_t.jpg", "img_caption": "AstraZeneca - A Big Pharma Company that is Ethical | British Heritage"}, {"img_url": "https://britishheritage.org/images/22/02/ru-1enzvtebbkr243_t.png", "img_caption": "AstraZeneca - A Big Pharma Company that is Ethical | British Heritage"}, {"img_url": "https://upload.wikimedia.org/wikipedia/en/thumb/4/4f/AstraZeneca.svg/440px-AstraZeneca.svg.png", "img_caption": "AstraZeneca - Wikiwand"}, {"img_url": "https://upload.wikimedia.org/wikipedia/commons/thumb/7/70/Oxford_AstraZeneca_COVID-19_vaccine_%282021%29_I_%28cropped%29.jpg/880px-Oxford_AstraZeneca_COVID-19_vaccine_%282021%29_I_%28cropped%29.jpg", "img_caption": "AstraZeneca wiki | TheReaderWiki"}]}
{"catalog": "D:\\project\\AspectMMKG\\Entities\\AstraZeneca\\History\\2013 restructuring and beyond\\2020", "query": "Entities\\AstraZeneca 2020", "images": [{"img_url": "https://khn.org/wp-content/uploads/sites/2/2020/08/GettyImages-1227715002.jpg", "img_caption": "They Pledged to Donate Rights to Their COVID Vaccine, Then Sold Them to  Pharma | Kaiser Health News"}, {"img_url": "https://media.nature.com/lw800/magazine-assets/d41573-021-00002-0/d41573-021-00002-0_18733640.jpg", "img_caption": "2020 FDA drug approvals"}, {"img_url": "https://gh.bmj.com/content/bmjgh/6/12/e007321/F5.large.jpg", "img_caption": "Who funded the research behind the Oxford–AstraZeneca COVID-19 vaccine? |  BMJ Global Health"}, {"img_url": "https://rwc340b.org/wp-content/uploads/2020/12/medications-257344_1920.jpg", "img_caption": "Astra-Zeneca Announces It Will No Longer Offer 340B Discounts at Most  Contract Pharmacies – RWC-340B"}, {"img_url": "https://gh.bmj.com/content/bmjgh/6/12/e007321/F1.large.jpg", "img_caption": "Who funded the research behind the Oxford–AstraZeneca COVID-19 vaccine? |  BMJ Global Health"}]}
{"catalog": "D:\\project\\AspectMMKG\\Entities\\AstraZeneca\\History\\2013 restructuring and beyond\\2020", "query": "AstraZeneca agreed to sublicense its global rights (except Europe", "images": [{"img_url": "https://www.ft.com/__origami/service/image/v2/images/raw/https%3A%2F%2Fd1e00ek4ebabms.cloudfront.net%2Fproduction%2Fc9c3fca3-6f44-4109-96ad-678613f420bc.jpg?source=next-opengraph&fit=scale-down&width=900", "img_caption": "Brussels publishes EU-AstraZeneca vaccine contract | Financial Times"}, {"img_url": "https://upload.wikimedia.org/wikipedia/commons/thumb/b/bf/AstraZeneca_HQ_in_Cambridge_UK.jpg/1200px-AstraZeneca_HQ_in_Cambridge_UK.jpg", "img_caption": "AstraZeneca - Wikipedia"}, {"img_url": "https://qtxasset.com/cdn-cgi/image/w=384,h=216,f=auto,fit=crop,g=0.5x0.5/https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1582644770/original.jpg/original.jpg?VersionId=6ClAb1tf3m.5mR55nB_Cb5IfrmjzfU_X", "img_caption": "AstraZeneca, still in asset-sale mode, hands off most global rights for  constipation med Movantik | Fierce Pharma"}, {"img_url": "https://qtxasset.com/cdn-cgi/image/w=384,h=216,f=auto,fit=crop,g=0.5x0.5/https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1611945645/PascalSoriot.jpg/PascalSoriot.jpg?VersionId=Bt8eGj5kFRDePQpJ.1rb.RvzejyRdVq6", "img_caption": "AstraZeneca's COVID-19 shot scores European authorization as production  holdups linger | Fierce Pharma"}, {"img_url": "https://www.ft.com/__origami/service/image/v2/images/raw/https%3A%2F%2Fd1e00ek4ebabms.cloudfront.net%2Fproduction%2Fc9c3fca3-6f44-4109-96ad-678613f420bc.jpg?source=next-opengraph&fit=scale-down&width=900", "img_caption": "Brussels publishes EU-AstraZeneca vaccine contract | Financial Times"}]}
{"catalog": "D:\\project\\AspectMMKG\\Entities\\AstraZeneca\\History\\2013 restructuring and beyond\\2020", "query": "AstraZeneca made a preliminary approach to Gilead Sciences about a potential merger", "images": [{"img_url": "https://ca-times.brightspotcdn.com/dims4/default/4f5a825/2147483647/strip/true/crop/2048x1257+0+0/resize/1486x912!/quality/90/?url=https%3A%2F%2Fcalifornia-times-brightspot.s3.amazonaws.com%2F88%2F13%2F91ab288a644b84b4eb45f4f6592f%2Fla-afp-getty-britain-pharma-business-astrazeneca-f-20140526", "img_caption": "AstraZeneca approaches Gilead about potential merger - Los Angeles Times"}, {"img_url": "https://static.theprint.in/wp-content/uploads/2020/09/Untitled-design-2020-09-09T080428.175.jpg", "img_caption": "AstraZeneca plans post-Covid growth with $39 billion deal with Alexion  Pharmaceuticals"}, {"img_url": "https://assets.bwbx.io/images/users/iqjWHBFdfxIU/ilv9xlf5f47A/v1/1200x600.jpg", "img_caption": "Merger News: AstraZeneca Approaches Gilead Sciences - Bloomberg"}, {"img_url": "https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1644524563/GettyImages-1288838574.jpg/GettyImages-1288838574.jpg?VersionId=jMg8iPpcnuQy.Vl4ESzWW25xXQszjp7i", "img_caption": "AstraZeneca's COVID vaccine sales reached $4B last year, but don't expect  that much in 2022 | Fierce Pharma"}, {"img_url": "https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1616674202/Coronavirus%20vaccine.jpg/Coronavirus%20vaccine.jpg?VersionId=gX3_dgudaldcSm2N0FsVsESm634iiURs", "img_caption": "AstraZeneca's COVID-19 vaccine defies data controversy with 76%  effectiveness in phase 3 | Fierce Pharma"}]}
{"catalog": "D:\\project\\AspectMMKG\\Entities\\AstraZeneca\\History\\2013 restructuring and beyond\\2020", "query": "AstraZeneca acquired the preclinical oral PCSK9 inhibitor program from Dogma Therapeutics", "images": [{"img_url": "https://mma.prnewswire.com/media/1275468/dogma_Logo.jpg", "img_caption": "Dogma Therapeutics Announces Global Acquisition of Oral PCSK9 Inhibitor  Program by AstraZeneca"}, {"img_url": "http://www.selectscience.net/images/articles/5569_astrazenecalogo4546.jpg", "img_caption": "AstraZeneca acquires oral PCSK9 inhibitor program from Dog"}, {"img_url": "https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/09/AstraZeneca-headquarters.jpg", "img_caption": "AstraZeneca acquires Dogma's oral PCSK9 inhibitor programme"}, {"img_url": "https://uploads-ssl.webflow.com/6113803127898e9649f1c2d0/611454601f20bf5773dd4ebf_5f63470139edf.png", "img_caption": "Dogma Therapeutics Reached the Acquisition Agreement with AstraZeneca on Dogma's  Oral PCSK9 Inhibitor Program"}, {"img_url": "https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2020/09/AstraZeneca_1709.jpg", "img_caption": "AstraZeneca acquires Dogma Therapeutics' PCSK9 inhibitor programme -  Pharmaceutical Technology"}]}
{"catalog": "D:\\project\\AspectMMKG\\Entities\\AstraZeneca\\History\\2013 restructuring and beyond\\2020", "query": "AstraZeneca CEO Pascal Soriot said that they have “figured out the winning formula” with their two-dose system with the Oxford University’s COVID-19 vaccine", "images": [{"img_url": "https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1609164975/PascalSoriot.jpg/PascalSoriot.jpg?VersionId=MojphD50fPXMjST1pmK3Ge4sZ.f3twKz", "img_caption": "AstraZeneca now has a 'winning formula' for its COVID-19 vaccine, CEO says  | Fierce Pharma"}, {"img_url": "https://img.rasset.ie/0015fb8f-614.jpg?ratio=1.78", "img_caption": "AstraZeneca Covid vaccine has 'winning formula': CEO"}, {"img_url": "https://static.timesofisrael.com/www/uploads/2020/12/AP20343519923424.jpg", "img_caption": "AstraZeneca: 'Winning' vaccine formula is 100% effective against severe  COVID-19 | The Times of Israel"}, {"img_url": "https://images.livemint.com/img/2020/12/30/600x338/2020-11-19T093517Z_1_LYNXMPEGAI0KP_RTROPTP_3_HEALTH-CORONAVIRUS-OXFORD-ASTRAZENECA-VACCINE_1605784666116_1605784682808_1609321735493.JPG", "img_caption": "AstraZeneca-Oxford vaccine: 5 things to know | Mint"}, {"img_url": "https://img.etimg.com/thumb/msid-80026461,width-1200,height-900,imgsize-187501,overlay-economictimes/photo.jpg", "img_caption": "UK Vaccine: AstraZeneca/Oxford vaccine: Five things to know about landmark  UK vaccine - The Economic Times"}]}
{"catalog": "D:\\project\\AspectMMKG\\Entities\\AstraZeneca\\History\\2013 restructuring and beyond\\2020", "query": "the United Kingdom approved the emergency use of the Oxford–AstraZeneca COVID-19 vaccine", "images": [{"img_url": "https://www.aljazeera.com/wp-content/uploads/2021/02/h_56686373.jpg?resize=770%2C513", "img_caption": "WHO approves Oxford-AstraZeneca COVID vaccine for emergency use | World  Health Organization News | Al Jazeera"}, {"img_url": "https://ichef.bbci.co.uk/news/976/cpsprodpb/104EB/production/_117759766_mediaitem117759763.jpg", "img_caption": "Covid: Germany limits use of AstraZeneca Covid jab for under-60s - BBC News"}, {"img_url": "https://www.cidrap.umn.edu/sites/default/files/styles/ss_media_popup/public/media/article/britishvaccine.jpg?itok=z0yyTx9Y", "img_caption": "UK becomes first country to green-light AstraZeneca COVID vaccine | CIDRAP"}, {"img_url": "https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1645719358/Coronavirus%20vaccine.jpg/Coronavirus%20vaccine.jpg?VersionId=tdJ_b9xU6EAiebcAnZNse1Lj_q13wbwr", "img_caption": "COVID-19 tracker: Biden is leaving isolation after testing negative twice"}, {"img_url": "https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2020/12/astrazeneca-uk-approval.jpg", "img_caption": "UK approves AstraZeneca's Covid-19 vaccine for emergency use"}]}
{"catalog": "D:\\project\\AspectMMKG\\Entities\\AstraZeneca\\History\\2013 restructuring and beyond\\2021", "query": "Entities\\AstraZeneca 2021", "images": [{"img_url": "https://www.reuters.com/resizer/avMoI5NgCtcOUablxeir9wn9KOE=/1080x565/smart/filters:quality(80)/cloudfront-us-east-2.images.arcpublishing.com/reuters/5OC7QDE6GJPEDKI7TVPDPLZ2LI.jpg", "img_caption": "AstraZeneca lifts revenue guidance on COVID treatment | Reuters"}, {"img_url": "https://www.pmlive.com/__data/assets/image/0016/1356100/NEW_AstraZeneca_shutterstock_1820522576-640.jpg", "img_caption": "AstraZeneca blocks take-private buyout of Sobi - PMLiVE"}, {"img_url": "https://img.industryweek.com/files/base/ebm/industryweek/image/2021/11/astrazeneca.618951ae612fb.png?auto=format,compress&fit=fill&fill=blur&w=1200&h=630", "img_caption": "Complexity, Speed and Cost Pressures: As Medicine Changes, So Does  AstraZeneca's Approach | IndustryWeek"}, {"img_url": "https://www.reuters.com/resizer/avMoI5NgCtcOUablxeir9wn9KOE=/1080x565/smart/filters:quality(80)/cloudfront-us-east-2.images.arcpublishing.com/reuters/5OC7QDE6GJPEDKI7TVPDPLZ2LI.jpg", "img_caption": "AstraZeneca lifts revenue guidance on COVID treatment | Reuters"}, {"img_url": "https://cloudfront-us-east-2.images.arcpublishing.com/reuters/66GCP47P7JLR5JXDJY77KVZH7E.jpg", "img_caption": "AstraZeneca invests in Imperial's self-amplifying RNA technology with eye  on future drugs | Reuters"}]}
{"catalog": "D:\\project\\AspectMMKG\\Entities\\AstraZeneca\\History\\2013 restructuring and beyond\\2021", "query": "AstraZeneca acquired Alexion Pharmaceuticals", "images": [{"img_url": "https://pharmaphorum.com/wp-content/uploads/2020/12/AZ_Alexion-605x340.jpg", "img_caption": "Alexion finally has a buyer – and it's AstraZeneca with $39bn on the table -"}, {"img_url": "https://pharmaphorum.com/wp-content/uploads/2020/12/AZ_Alexion.jpg", "img_caption": "Alexion finally has a buyer – and it's AstraZeneca with $39bn on the table -"}, {"img_url": "https://www.massdevice.com/wp-content/uploads/2020/12/AstraZeneca-Logo-2.jpg", "img_caption": "AstraZeneca to acquire Alexion for $39B - MassDevice"}, {"img_url": "https://www.drugdiscoverytrends.com/wp-content/uploads/2020/12/AstraZeneca-Logo-2-300x195.jpg", "img_caption": "AstraZeneca to acquire Alexion for $39B - Drug Discovery and Development"}, {"img_url": "https://mergerarbitragelimited.com/wp-content/uploads/AZN-ALXN.jpg", "img_caption": "AstraZeneca (AZN) and Alexion (ALXN) Merger – Merger Arbitrage Limited"}]}
{"catalog": "D:\\project\\AspectMMKG\\Entities\\AstraZeneca\\History\\2013 restructuring and beyond\\2022", "query": "Entities\\AstraZeneca 2022", "images": [{"img_url": "https://www.pmlive.com/__data/assets/image/0016/1356100/NEW_AstraZeneca_shutterstock_1820522576-640.jpg", "img_caption": "AstraZeneca blocks take-private buyout of Sobi - PMLiVE"}, {"img_url": "https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1628694126/GettyImages-1288838574.jpg/GettyImages-1288838574.jpg?VersionId=ak64CIs5nurK9.a3p74AD4NWUwuslNnK", "img_caption": "Facebook bans ad agency behind outlandish campaign deriding Pfizer,  AstraZeneca vaccines | Fierce Pharma"}, {"img_url": "https://upload.wikimedia.org/wikipedia/commons/thumb/b/bf/AstraZeneca_HQ_in_Cambridge_UK.jpg/1200px-AstraZeneca_HQ_in_Cambridge_UK.jpg", "img_caption": "AstraZeneca - Wikipedia"}, {"img_url": "https://cloudfront-us-east-2.images.arcpublishing.com/reuters/5OC7QDE6GJPEDKI7TVPDPLZ2LI.jpg", "img_caption": "AstraZeneca lifts revenue guidance on COVID treatment | Reuters"}, {"img_url": "https://cloudfront-us-east-2.images.arcpublishing.com/reuters/FFKKCVHRJZP2BDWS4AH2AR4BA4.jpg", "img_caption": "AstraZeneca sees higher 2022 sales even as COVID boost wanes | Reuters"}]}
{"catalog": "D:\\project\\AspectMMKG\\Entities\\AstraZeneca\\Notes", "query": "Entities\\AstraZeneca Notes", "images": [{"img_url": "https://gh.bmj.com/content/bmjgh/6/12/e007321/F1.large.jpg", "img_caption": "Who funded the research behind the Oxford–AstraZeneca COVID-19 vaccine? |  BMJ Global Health"}, {"img_url": "https://khn.org/wp-content/uploads/sites/2/2020/08/GettyImages-1227715002.jpg?w=1270", "img_caption": "They Pledged to Donate Rights to Their COVID Vaccine, Then Sold Them to  Pharma | Kaiser Health News"}, {"img_url": "https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs43018-022-00332-x/MediaObjects/43018_2022_332_Fig1_HTML.png", "img_caption": "The Molecular Tumor Board Portal supports clinical decisions and automated  reporting for precision oncology | Nature Cancer"}, {"img_url": "https://cloudfront-us-east-2.images.arcpublishing.com/reuters/5OC7QDE6GJPEDKI7TVPDPLZ2LI.jpg", "img_caption": "AstraZeneca lifts revenue guidance on COVID treatment | Reuters"}, {"img_url": "https://cloudfront-us-east-2.images.arcpublishing.com/reuters/66GCP47P7JLR5JXDJY77KVZH7E.jpg", "img_caption": "AstraZeneca invests in Imperial's self-amplifying RNA technology with eye  on future drugs | Reuters"}]}
{"catalog": "D:\\project\\AspectMMKG\\Entities\\AstraZeneca\\Operations", "query": "Entities\\AstraZeneca Operations", "images": [{"img_url": "https://tbcdn.talentbrew.com/company/7684/14641/Content/AZ2460%20GPTW%20Japan%20Operations.jpg", "img_caption": "Operations"}, {"img_url": "https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1628694126/GettyImages-1288838574.jpg/GettyImages-1288838574.jpg?VersionId=ak64CIs5nurK9.a3p74AD4NWUwuslNnK", "img_caption": "Facebook bans ad agency behind outlandish campaign deriding Pfizer,  AstraZeneca vaccines | Fierce Pharma"}, {"img_url": "https://img.industryweek.com/files/base/ebm/industryweek/image/2021/11/astrazeneca.618951ae612fb.png?auto=format,compress&fit=fill&fill=blur&w=1200&h=630", "img_caption": "Complexity, Speed and Cost Pressures: As Medicine Changes, So Does  AstraZeneca's Approach | IndustryWeek"}, {"img_url": "https://www.drugdiscoverytrends.com/wp-content/uploads/2021/05/astrazeneca-thumb.png", "img_caption": "AstraZeneca - Drug Discovery and Development"}, {"img_url": "https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1604016256/AstraZeneca%20manufacturing.jpg/AstraZeneca%20manufacturing.jpg?VersionId=UXzpGb1ROS9VOOKHVfl1VSmYwjYAMDYp", "img_caption": "The top 10 manufacturers in the fight against COVID-19 | Fierce Pharma"}]}
{"catalog": "D:\\project\\AspectMMKG\\Entities\\AstraZeneca\\Operations", "query": "AstraZeneca develops", "images": [{"img_url": "https://image.cnbcfm.com/api/v1/image/106548842-1590147760503gettyimages-1213735348.jpeg?v=1592301976&w=929&h=523", "img_caption": "AstraZeneca is set to make two billion doses of a coronavirus vaccine"}, {"img_url": "https://khn.org/wp-content/uploads/sites/2/2020/08/GettyImages-1227715002.jpg?w=1270", "img_caption": "They Pledged to Donate Rights to Their COVID Vaccine, Then Sold Them to  Pharma | Kaiser Health News"}, {"img_url": "https://static.dw.com/image/17608482_303.jpg", "img_caption": "AstraZeneca COVID vaccine′s complex EU supply chain | Business | Economy  and finance news from a German perspective | DW | 02.02.2021"}, {"img_url": "https://www.ft.com/__origami/service/image/v2/images/raw/https%3A%2F%2Fd1e00ek4ebabms.cloudfront.net%2Fproduction%2F9ec0ef19-f070-4621-8f9c-1875d74506e2.jpg?fit=scale-down&source=next&width=700", "img_caption": "AstraZeneca vaccine document shows limit of no-profit pledge | Financial  Times"}, {"img_url": "https://i.guim.co.uk/img/media/52e0dd129543159964415dcd4c54f7ced8a973cf/0_498_7360_4414/master/7360.jpg?width=1200&height=1200&quality=85&auto=format&fit=crop&s=25557de9e701ab19478cb1d093ba8759", "img_caption": "Oxford AstraZeneca vaccine to be sold to developing countries at cost price  | Global development | The Guardian"}]}
{"catalog": "D:\\project\\AspectMMKG\\Entities\\AstraZeneca\\Operations", "query": "AstraZeneca has its corporate headquarters in Cambridge", "images": [{"img_url": "https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2017/05/Featured-Image-AstraZeneca-RD-Centre-and-Corporate-Headquarters-1038x720.jpg", "img_caption": "AstraZeneca R&D Centre and Corporate Headquarters, Cambridge, UK"}, {"img_url": "https://www.architecturalrecord.com/ext/resources/news/2021/November/AstraZeneca/AstraZeneca-2.jpg?height=635&t=1638144317&width=1200", "img_caption": "AstraZeneca Unveils a New Headquarters in Cambridge | 2021-11-28 |  Architectural Record"}, {"img_url": "https://www.architecturalrecord.com/ext/resources/news/2021/November/AstraZeneca/AstraZeneca-1.jpg?t=1638144366&width=900", "img_caption": "AstraZeneca Unveils a New Headquarters in Cambridge | 2021-11-28 |  Architectural Record"}, {"img_url": "https://www.architecturalrecord.com/ext/resources/news/2021/November/AstraZeneca/AstraZeneca-3.jpg?t=1638144289&width=900", "img_caption": "AstraZeneca Unveils a New Headquarters in Cambridge | 2021-11-28 |  Architectural Record"}, {"img_url": "https://www.understandinganimalresearch.org.uk/application/files/thumbnails/page_2x/7714/2305/4895/View-from-Robinson-way-North.jpg", "img_caption": "AstraZeneca plans for Cambridge HQ get go-ahead :: Understanding Animal  Research"}]}
{"catalog": "D:\\project\\AspectMMKG\\Entities\\AstraZeneca\\Orphan drugs", "query": "Entities\\AstraZeneca Orphan drugs", "images": [{"img_url": "https://www.dcatvci.org/wp-content/uploads/2021/09/Figure_1-_Percentage_of_NMEs_Approved_as_Orphan_Drugs.png", "img_caption": "Orphan Drugs: Bearing Revenue Gains or Not? - DCAT Value Chain Insights"}, {"img_url": "https://www.dcatvci.org/wp-content/uploads/2022/05/Figure-2-Orphan-Drugs-1024x720.png", "img_caption": "Market Outlook for Orphan Drugs: Niche No More - DCAT Value Chain Insights"}, {"img_url": "https://www.dcatvci.org/wp-content/uploads/2022/05/Figure-3-Orphan-Drugs-1024x652.png", "img_caption": "Market Outlook for Orphan Drugs: Niche No More - DCAT Value Chain Insights"}, {"img_url": "https://www.thebusinessresearchcompany.com/infographimages/211001_Orphan_Drugs_Market.png", "img_caption": "Orphan Drugs Market Analysis, Size And Trends Global Forecast To 2022-2030"}, {"img_url": "https://6erxg60qvo1qvjha44jrgpan-wpengine.netdna-ssl.com/wp-content/uploads/2019/02/Rare-disease-day--e1551360777322.jpg", "img_caption": "PharmaBoardroom - Why Invest in Rare Diseases & Orphan Drugs?"}]}
{"catalog": "D:\\project\\AspectMMKG\\Entities\\AstraZeneca\\Orphan drugs", "query": "AstraZeneca's drug tremelimumab was approved as an orphan drug for the treatment of mesothelioma in the United States", "images": [{"img_url": "https://qtxasset.com/cdn-cgi/image/w=384,h=216,f=auto,fit=crop,g=0.5x0.5/https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1631189511/Durvalumab_0.jpg/Durvalumab_0.jpg?VersionId=LeJy29NH27PCzD8D.ehemozUqjh5SppH", "img_caption": "FDA puts AZ's Imfinzi, tremelimumab combo under priority review"}, {"img_url": "https://www.mesotheliomahelp.org/wp-content/uploads/2016/02/Tremelimumab-as-treatment-for-malignant-mesothelioma.jpg", "img_caption": "Tremelimumab In Trial With Combination Therapy"}, {"img_url": "https://www.asbestos.com/wp-content/uploads/cancer_cell_immunotherapy-480x0-c-default.jpg", "img_caption": "Tremelimumab - FDA Approval & Mesothelioma Clinical Trials"}, {"img_url": "https://mms.businesswire.com/media/20220425005340/en/484259/22/Logo.jpg", "img_caption": "Tremelimumab accepted under Priority Review in the US for patients with  unresectable liver cancer in combination with Imfinzi | Business Wire"}, {"img_url": "https://www.mesotheliomahelp.org/wp-content/uploads/2018/03/Why-Is-Mesothelioma-Increasing.jpg", "img_caption": "Failure of the Promising Mesothelioma Treatment | MesotheliomaHelp.org"}]}
{"catalog": "D:\\project\\AspectMMKG\\Entities\\AstraZeneca\\Orphan drugs", "query": "AstraZeneca announced that a clinical trial of tremelimumab as a treatment for mesothelioma failed to meet its primary endpoint", "images": [{"img_url": "https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/ddb5bfc7-364a-4c46-95a3-bb53b705bddf/gr1.gif", "img_caption": "Tremelimumab as second-line or third-line treatment in relapsed malignant  mesothelioma (DETERMINE): a multicentre, international, randomised,  double-blind, placebo-controlled phase 2b trial - The Lancet Oncology"}, {"img_url": "https://www.mesotheliomahelp.org/wp-content/uploads/2018/03/Why-Is-Mesothelioma-Increasing.jpg", "img_caption": "Failure of the Promising Mesothelioma Treatment | MesotheliomaHelp.org"}, {"img_url": "https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/7010e890-b4b6-403c-aaa1-4b3ce99c977c/gr2_lrg.jpg", "img_caption": "Tremelimumab as second-line or third-line treatment in relapsed malignant  mesothelioma (DETERMINE): a multicentre, international, randomised,  double-blind, placebo-controlled phase 2b trial - The Lancet Oncology"}, {"img_url": "https://qtxasset.com/cdn-cgi/image/w=384,h=216,f=auto,fit=crop,g=0.5x0.5/https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1584454527/Durvalumab_0.jpg/Durvalumab_0.jpg?VersionId=a8FJeiG.jra1I80YG4f4qnf1XH6ZaqcP", "img_caption": "AstraZeneca's tremelimumab records another miss as Imfinzi combo strikes  out in small cell lung cancer | Fierce Pharma"}, {"img_url": "https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/da6c315f-ff74-46a3-a1f6-5bbea2c78091/gr1_lrg.jpg", "img_caption": "Scientific Advances and New Frontiers in Mesothelioma Therapeutics -  Journal of Thoracic Oncology"}]}
{"catalog": "D:\\project\\AspectMMKG\\Entities\\AstraZeneca\\Outreach", "query": "Entities\\AstraZeneca Outreach", "images": [{"img_url": "https://www.kff.org/wp-content/uploads/2020/10/FEATURE-Covid-Vaccine-Distribution_1-2.png", "img_caption": "Distributing a COVID-19 Vaccine Across the U.S. – A Look at Key Issues –  Issue Brief – 9563 | KFF"}, {"img_url": "https://www.tpchd.org/home/showpublishedimage/9956/637680745078100000", "img_caption": "COVID-19 Vaccine Community Outreach Toolkit | Tacoma-Pierce County Health  Department"}, {"img_url": "https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1614281660/GettyImages-1218961180.jpg/GettyImages-1218961180.jpg?VersionId=3VSiZr6yc5lQTka31uai8.avKVYOCzhM", "img_caption": "What does it take to supply COVID-19 vaccines across the globe? Here's how  the leading players are working it | Fierce Pharma"}, {"img_url": "https://cdn.cfr.org/sites/default/files/styles/open_graph/public/image/2021/06/rtxd3lfc.jpg", "img_caption": "Corporate Program Young Professionals Briefing: Fact, Fear, and Falsehood:  COVID-19 and the State of Global Vaccine Hesitancy | Council on Foreign  Relations"}, {"img_url": "https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1604016256/AstraZeneca%20manufacturing.jpg/AstraZeneca%20manufacturing.jpg?VersionId=UXzpGb1ROS9VOOKHVfl1VSmYwjYAMDYp", "img_caption": "The top 10 manufacturers in the fight against COVID-19 | Fierce Pharma"}]}
{"catalog": "D:\\project\\AspectMMKG\\Entities\\AstraZeneca\\Outreach\\Political lobbying", "query": "Entities\\AstraZeneca Political lobbying", "images": [{"img_url": "https://www.statnews.com/wp-content/uploads/2020/08/Prescription-Politics-Social-Card-Image.png", "img_caption": "Pharma is showering Congress with cash, even amid coronavirus"}, {"img_url": "https://www.statnews.com/wp-content/uploads/2020/08/industry-comparison-chart-768x483.png", "img_caption": "Pharma is showering Congress with cash, even amid coronavirus"}, {"img_url": "https://www.statnews.com/wp-content/uploads/2020/08/Party-Breakdown-v5-1-1-768x484.png", "img_caption": "Pharma is showering Congress with cash, even amid coronavirus"}, {"img_url": "https://i0.wp.com/publicintegrity.org/wp-content/uploads/2016/02/Screen-Shot-2018-12-20-at-9.23.46-AM.png?resize=780%2C472&ssl=1", "img_caption": "Amid federal gridlock, lobbying rises in the states – Center for Public  Integrity"}, {"img_url": "https://khn.org/wp-content/uploads/sites/2/2020/08/GettyImages-1227715002.jpg", "img_caption": "They Pledged to Donate Rights to Their COVID Vaccine, Then Sold Them to  Pharma | Kaiser Health News"}]}
{"catalog": "D:\\project\\AspectMMKG\\Entities\\AstraZeneca\\Outreach\\Political lobbying", "query": "AstraZeneca is a member of the Personalized Medicine Coalition", "images": [{"img_url": "https://www.futuremedicine.com/cms/10.2217/pme-2016-0064/asset/images/medium/figure1.gif", "img_caption": "Strategies for integrating personalized medicine into healthcare practice | Personalized  Medicine"}, {"img_url": "https://www.mdpi.com/jpm/jpm-12-01025/article_deploy/html/images/jpm-12-01025-ag.png", "img_caption": "JPM | Free Full-Text | Stakeholders Perceptions of Barriers to Precision  Medicine Adoption in the United States"}, {"img_url": "https://ppuse1-economist-event-media.s3.amazonaws.com/wp-content/uploads/2019/12/13095602/PMC-2.png", "img_caption": "Targeting Cancer | Economist Impact events"}, {"img_url": "https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41591-022-01717-2/MediaObjects/41591_2022_1717_Fig1_HTML.png", "img_caption": "Delivering precision oncology to patients with cancer | Nature Medicine"}, {"img_url": "https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/c0547203-d7c7-4471-bd9b-1440f4613981/gr1_lrg.jpg", "img_caption": "Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against  SARS-CoV-2: an interim analysis of four randomised controlled trials in  Brazil, South Africa, and the UK - The Lancet"}]}
{"catalog": "D:\\project\\AspectMMKG\\Entities\\AstraZeneca\\References", "query": "Entities\\AstraZeneca References", "images": [{"img_url": "https://gh.bmj.com/content/bmjgh/6/12/e007321/F1.large.jpg", "img_caption": "Who funded the research behind the Oxford–AstraZeneca COVID-19 vaccine? |  BMJ Global Health"}, {"img_url": "https://khn.org/wp-content/uploads/sites/2/2020/08/GettyImages-1227715002.jpg", "img_caption": "They Pledged to Donate Rights to Their COVID Vaccine, Then Sold Them to  Pharma | Kaiser Health News"}, {"img_url": "https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41591-021-01230-y/MediaObjects/41591_2021_1230_Fig1_HTML.png", "img_caption": "Looking beyond COVID-19 vaccine phase 3 trials | Nature Medicine"}, {"img_url": "https://upload.wikimedia.org/wikipedia/commons/thumb/b/bf/AstraZeneca_HQ_in_Cambridge_UK.jpg/640px-AstraZeneca_HQ_in_Cambridge_UK.jpg", "img_caption": "AstraZeneca - Wikipedia"}, {"img_url": "https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1628694126/GettyImages-1288838574.jpg/GettyImages-1288838574.jpg?VersionId=ak64CIs5nurK9.a3p74AD4NWUwuslNnK", "img_caption": "Facebook bans ad agency behind outlandish campaign deriding Pfizer,  AstraZeneca vaccines | Fierce Pharma"}]}
{"catalog": "D:\\project\\AspectMMKG\\Entities\\AstraZeneca\\See also", "query": "Entities\\AstraZeneca See also", "images": [{"img_url": "https://www.reuters.com/resizer/avMoI5NgCtcOUablxeir9wn9KOE=/1080x565/smart/filters:quality(80)/cloudfront-us-east-2.images.arcpublishing.com/reuters/5OC7QDE6GJPEDKI7TVPDPLZ2LI.jpg", "img_caption": "AstraZeneca lifts revenue guidance on COVID treatment | Reuters"}, {"img_url": "https://khn.org/wp-content/uploads/sites/2/2020/08/GettyImages-1227715002.jpg", "img_caption": "They Pledged to Donate Rights to Their COVID Vaccine, Then Sold Them to  Pharma | Kaiser Health News"}, {"img_url": "https://gh.bmj.com/content/bmjgh/6/12/e007321/F1.large.jpg", "img_caption": "Who funded the research behind the Oxford–AstraZeneca COVID-19 vaccine? |  BMJ Global Health"}, {"img_url": "https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/cc701e18-f412-4e02-bde7-57fe8cff6720/gr1.jpg", "img_caption": "The COVID-19 puzzle: deciphering pathophysiology and phenotypes of a new  disease entity - The Lancet Respiratory Medicine"}, {"img_url": "https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1628694126/GettyImages-1288838574.jpg/GettyImages-1288838574.jpg?VersionId=ak64CIs5nurK9.a3p74AD4NWUwuslNnK", "img_caption": "Facebook bans ad agency behind outlandish campaign deriding Pfizer,  AstraZeneca vaccines | Fierce Pharma"}]}
{"catalog": "D:\\project\\AspectMMKG\\Entities\\AstraZeneca\\Senior management", "query": "Entities\\AstraZeneca Senior management", "images": [{"img_url": "https://www.ft.com/__origami/service/image/v2/images/raw/https%3A%2F%2Fd1e00ek4ebabms.cloudfront.net%2Fproduction%2F20894411-197e-4c45-842e-5c33771b1b16.jpg?source=next-opengraph&fit=scale-down&width=900", "img_caption": "How AstraZeneca's vaccine was hit by flawed trials, defects and politics —  but might still save the world | Financial Times"}, {"img_url": "https://ceoroundtable.heart.org/wp-content/uploads/2018/04/AstraZeneca-Pascal_Soriot-1.jpg", "img_caption": "AstraZeneca - CEO Roundtable"}, {"img_url": "https://flow.db.com/contentAsset/image/2b83d9bb-e7d8-4f60-9038-ad2ee715d48a/fileAsset/filter/Resize,Jpeg/resize_w/1280/81924df1-3a58-444e-9f8f-254f4215db94.jpg", "img_caption": "The personal touch – Deutsche Bank"}, {"img_url": "https://dist.neo4j.com/wp-content/uploads/20200622230851/image-1-5.jpg", "img_caption": "Graphs in Healthcare: Improving Patient Outcomes with Graph Algorithms"}, {"img_url": "https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fnrd4309/MediaObjects/41573_2014_Article_BFnrd4309_Fig1_HTML.jpg", "img_caption": "Lessons learned from the fate of AstraZeneca's drug pipeline: a  five-dimensional framework | Nature Reviews Drug Discovery"}]}
{"catalog": "D:\\project\\AspectMMKG\\Entities\\AstraZeneca\\Senior management", "query": "Pascal Soriot was named CEO of AstraZeneca", "images": [{"img_url": "https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1621864054/PascalSoriot.jpg/PascalSoriot.jpg?VersionId=oDgOtyUjqYq9ZVO451wYs9MlqFL.FLEu", "img_caption": "AstraZeneca CEO Soriot defends COVID-19 vaccine, blasts 'armchair generals'  for unhelpful criticism: FT | Fierce Pharma"}, {"img_url": "https://qtxasset.com/quartz/qcloud5/media/image/2016-08/Pascal%20Soriot%20.jpeg?VersionId=JQcn0ukPLZdLEYuXtcb96KggnL_uVmCC", "img_caption": "If AstraZeneca CEO Soriot does take Teva's helm, what comes next?  Megamerger talk, maybe | Fierce Pharma"}, {"img_url": "https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1542641581/soriot111.jpg/soriot111.jpg?VersionId=3L4qUBV2qfQcZnvp8xx_9BUx3b7U3Cjf", "img_caption": "Is AstraZeneca lining up candidates to succeed CEO Soriot? | Fierce Pharma"}, {"img_url": "https://assets.bwbx.io/images/users/iqjWHBFdfxIU/iNbJeCxpTr4U/v95/-1x-1.jpg", "img_caption": "Watch Leaders with Lacqua: Astrazeneca CEO Pascal Soriot - Bloomberg"}, {"img_url": "https://image.cnbcfm.com/api/v1/image/106695790-1599668115276-gettyimages-1059051064-UK_ASTRAZENECA.jpeg?v=1599668180&w=720&h=405", "img_caption": "AstraZeneca investors narrowly approve CEO's 2021 pay package"}]}
{"catalog": "D:\\project\\AspectMMKG\\Entities\\AstraZeneca\\Vaxzevria, AstraZeneca's COVID-19 pandemic response", "query": "Entities\\AstraZeneca Vaxzevria, AstraZeneca's COVID-19 pandemic response", "images": [{"img_url": "https://www.ipd.uw.edu/wp-content/uploads/2022/06/SKYCovione.jpeg", "img_caption": "Coronavirus – Institute for Protein Design"}, {"img_url": "https://www.genengnews.com/wp-content/uploads/2020/05/thumbnail_Mar1_2020_GettyImages_1203771991_Coronavirus-1068x657-FILTER-111.jpg", "img_caption": "COVID-19 Vaccine AstraZeneca (marketed in some countries as Vaxzevria or  Covishield; formerly AZD1222 and ChadOx1 nCoV-19)"}, {"img_url": "https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1597166780/coronavirus.jpg?VersionId=Gtjee3PxV5ivgiq4ZJYiOPh1ttUGV821", "img_caption": "COVID-19 tracker: Regeneron's antibody cocktail hit by safety concerns;  Novo's Rybelsus emerging from pandemic slump | Fierce Pharma"}, {"img_url": "https://www.certifico.com/images/news2021/Vaxzevria.png", "img_caption": "Vaxzevria (previously COVID-19 Vaccine AstraZeneca) - Certifico Srl"}, {"img_url": "https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1619703711/GettyImages-1293456793.jpg/GettyImages-1293456793.jpg?VersionId=WB8tj9FiBVgpCnJxtaqj0TT3Gnf4tWIM", "img_caption": "COVID-19 tracker: Omicron variant could cause global surge, WHO says; J&J  recipients opt for other boosters | Fierce Pharma"}]}
{"catalog": "D:\\project\\AspectMMKG\\Entities\\AstraZeneca\\Vaxzevria, AstraZeneca's COVID-19 pandemic response\\Lawsuits", "query": "Entities\\AstraZeneca Lawsuits", "images": [{"img_url": "https://qtxasset.com/cdn-cgi/image/w=384,h=216,f=auto,fit=crop,g=0.5x0.5/https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1635175749/Durvalumab_0.jpg/Durvalumab_0.jpg?VersionId=ACfHjP.gbDxGFoOp5Nv7yKn.JkKn0Gcn", "img_caption": "AstraZeneca faces $278M Imfinzi patent infringement lawsuit from  co-developer Ono | Fierce Pharma"}, {"img_url": "https://cloudfront-us-east-2.images.arcpublishing.com/reuters/66GCP47P7JLR5JXDJY77KVZH7E.jpg", "img_caption": "AstraZeneca invests in Imperial's self-amplifying RNA technology with eye  on future drugs | Reuters"}, {"img_url": "https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1638789596/original.png/original.png?VersionId=WV0K0MM1UrRwIDgaRHPeEsdKdWn1ycGQ", "img_caption": "AstraZeneca weighs spinning out COVID-19 products into separate company:  Bloomberg | Fierce Pharma"}, {"img_url": "https://340breport.com/wp-content/uploads/2022/06/rendered-1-940x510.png", "img_caption": "Feds Urge Appeals Court to Overrule Lower Court in AstraZeneca's 340B  Contract Pharmacy Lawsuit – 340B Report"}, {"img_url": "https://assets.bwbx.io/images/users/iqjWHBFdfxIU/iJ9.llWYbEbQ/v0/1200x-1.jpg", "img_caption": "AstraZeneca's Vaccine Testing Stumble Draws Investor Lawsuit - Bloomberg"}]}
{"catalog": "D:\\project\\AspectMMKG\\Entities\\AstraZeneca\\Vaxzevria, AstraZeneca's COVID-19 pandemic response\\Lawsuits", "query": "the lawsuit was finally settled with AstraZeneca agreeing to deliver 60 million doses of vaccines to EU member states by October", "images": [{"img_url": "https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1645719358/Coronavirus%20vaccine.jpg/Coronavirus%20vaccine.jpg?VersionId=tdJ_b9xU6EAiebcAnZNse1Lj_q13wbwr", "img_caption": "GlaxoSmithKline, Medicago's plant-based COVID vaccine, Covifenz, wins first  approval | Fierce Pharma"}, {"img_url": "https://qtxasset.com/cdn-cgi/image/w=384,h=216,f=auto,fit=crop,g=0.5x0.5/https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1611590068/Screen%20Shot%202021-01-04%20at%2010.38.41%20AM.png/Screen%20Shot%202021-01-04%20at%2010.38.41%20AM.png?VersionId=ULtybx6fEuNo5OLNae2uLy1iIU5RjQ2I", "img_caption": "AstraZeneca's surprise COVID-19 vaccine shortfall prompts Europe to press  for answers | Fierce Pharma"}, {"img_url": "https://qtxasset.com/quartz/qcloud5/media/image/GettyImages-1354200289.jpg?VersionId=HotptMKOeZCaKw0d04XxzjXn8KhCmdg2", "img_caption": "Pfizer already agreed to delay supply of COVID-19 shots to EU, now the bloc  wants more"}, {"img_url": "https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1616501240/GettyImages-1218961180.jpg/GettyImages-1218961180.jpg?VersionId=TXLYNLM4VPrwRDkaEQhIbY5Nqq30oH1K", "img_caption": "AstraZeneca scrambles to update COVID-19 vaccine data after NIH flags  'concerns' about Monday's triumphant release | Fierce Pharma"}, {"img_url": "https://www.politico.eu/cdn-cgi/image/width=1200,height=630,fit=crop,quality=80,onerror=redirect/wp-content/uploads/2021/09/03/GettyImages-1234866163-scaled.jpg", "img_caption": "EU and AstraZeneca settle court case over vaccine supply – POLITICO"}]}
{"catalog": "D:\\project\\AspectMMKG\\Entities\\AstraZeneca\\Vaxzevria, AstraZeneca's COVID-19 pandemic response\\Name change", "query": "Entities\\AstraZeneca Name change", "images": [{"img_url": "https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1628694126/GettyImages-1288838574.jpg/GettyImages-1288838574.jpg?VersionId=ak64CIs5nurK9.a3p74AD4NWUwuslNnK", "img_caption": "Facebook bans ad agency behind outlandish campaign deriding Pfizer,  AstraZeneca vaccines | Fierce Pharma"}, {"img_url": "https://live-production.wcms.abc-cdn.net.au/d6397566d735dd9b86adf46d3ae72949?impolicy=wcms_crop_resize&cropH=2444&cropW=3258&xPos=0&yPos=76&width=862&height=647", "img_caption": "AstraZeneca COVID vaccine name changed to Vaxzevria - ABC News"}, {"img_url": "https://cdn.newsapi.com.au/image/v1/612d25a5a54b2ac24ddd843f03168544", "img_caption": "AstraZeneca to change vaccine name to Vaxzevria in Australia"}, {"img_url": "https://live-production.wcms.abc-cdn.net.au/d7530d81e6a5a6dafaf05ac625e31aea?impolicy=wcms_crop_resize&cropH=1688&cropW=3000&xPos=0&yPos=77&width=862&height=485", "img_caption": "AstraZeneca COVID vaccine name changed to Vaxzevria - ABC News"}, {"img_url": "https://upload.wikimedia.org/wikipedia/commons/thumb/d/dd/Oxford_AstraZeneca_COVID-19_vaccine_AZD1222_-_4.jpg/1200px-Oxford_AstraZeneca_COVID-19_vaccine_AZD1222_-_4.jpg", "img_caption": "Oxford–AstraZeneca COVID-19 vaccine - Wikipedia"}]}
{"catalog": "D:\\project\\AspectMMKG\\Entities\\AstraZeneca\\Vaxzevria, AstraZeneca's COVID-19 pandemic response\\Side-effects", "query": "Entities\\AstraZeneca Side-effects", "images": [{"img_url": "https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41586-020-2798-3/MediaObjects/41586_2020_2798_Fig1_HTML.png", "img_caption": "SARS-CoV-2 vaccines in development | Nature"}, {"img_url": "https://media.nature.com/lw800/magazine-assets/d41586-021-00290-x/d41586-021-00290-x_18857840.png", "img_caption": "COVID vaccines and safety: what the research says"}, {"img_url": "https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41541-021-00292-w/MediaObjects/41541_2021_292_Fig1_HTML.png", "img_caption": "SARS-CoV-2 vaccines strategies: a comprehensive review of phase 3  candidates | npj Vaccines"}, {"img_url": "https://ichef.bbci.co.uk/news/640/cpsprodpb/3A97/production/_116299941_oxford_coronavirus_vaccine_640_3x-nc.png", "img_caption": "EU drug regulator: Unusual blood clot is 'very rare AstraZeneca side effect'  - BBC News"}, {"img_url": "https://ichef.bbci.co.uk/news/640/cpsprodpb/6CE6/production/_117887872_vaccine_death_comparison_640-nc.png", "img_caption": "Covid-19 vaccines: What's happening to unused jabs? - BBC News"}]}
{"catalog": "D:\\project\\AspectMMKG\\Entities\\AstraZeneca\\Vaxzevria, AstraZeneca's COVID-19 pandemic response\\Side-effects", "query": "EMA head of vaccines Marco Cavaleri announced that it could be declared that there was a link between the Oxford–AstraZeneca COVID-19 (Vaxzevria) vaccine and rare blood clots associated with low platelet counts", "images": [{"img_url": "https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1617219379/GettyImages-1218961180.jpg/GettyImages-1218961180.jpg?VersionId=UZdpyGY2Qjy7rjCKZUipRcWaUtbDo33z", "img_caption": "AstraZeneca's COVID vaccine faces new round of restrictions—even after the  EMA's renewed backing | Fierce Pharma"}, {"img_url": "https://image.cnbcfm.com/api/v1/image/106857871-16164993092021-03-23t084630z_204992220_rc2wgm9254i5_rtrmadp_0_health-coronavirus-philippines.jpeg?v=1616499373", "img_caption": "AstraZeneca Covid vaccine: EMA finds possible link to rare blood clotting  problem"}, {"img_url": "https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1641307110/GettyImages-1288838574.jpg/GettyImages-1288838574.jpg?VersionId=JNV5LPUnEv2pYsOknVSpSEypBxOcspsv", "img_caption": "COVID-19 tracker: Japan cancels part of AZ vaccine order | Fierce Pharma"}, {"img_url": "https://static.reuters.com/resources/r/?m=02&d=20210406&t=2&i=1557460007&r=LYNXMPEH350PF&w=800", "img_caption": "Clear link between AstraZeneca vaccine and rare blood clots in brain, EMA  official tells paper | Reuters"}, {"img_url": "https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1620400124/Screen%20Shot%202021-01-04%20at%2010.38.41%20AM.png/Screen%20Shot%202021-01-04%20at%2010.38.41%20AM.png?VersionId=MfHQ9NLEIDWgl4k9NlUPMPEF0lnRaO8J", "img_caption": "Pfizer, AstraZeneca COVID vaccines probed in Europe after reports of heart  inflammation, rare nerve disorder | Fierce Pharma"}]}
{"catalog": "D:\\project\\AspectMMKG\\Entities\\AstraZeneca\\Vaxzevria, AstraZeneca's COVID-19 pandemic response\\The road to authorisation by the European Medicines Agency", "query": "Entities\\AstraZeneca The road to authorisation by the European Medicines Agency", "images": [{"img_url": "https://pbs.twimg.com/media/Es6JWDdXYAYpgss?format=jpg&name=small", "img_caption": "EU approves AstraZeneca coronavirus vaccine | News | DW | 29.01.2021"}, {"img_url": "https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1628694126/GettyImages-1288838574.jpg/GettyImages-1288838574.jpg?VersionId=ak64CIs5nurK9.a3p74AD4NWUwuslNnK", "img_caption": "Facebook bans ad agency behind outlandish campaign deriding Pfizer,  AstraZeneca vaccines | Fierce Pharma"}, {"img_url": "https://www.tribecaknowledge.com/hubfs/2021%20New%20Drug%20Approvals-png.png", "img_caption": "2021 New Drug Approvals: Review of FDA and EMA Marketing Authorisations"}, {"img_url": "https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41591-021-01230-y/MediaObjects/41591_2021_1230_Fig1_HTML.png", "img_caption": "Looking beyond COVID-19 vaccine phase 3 trials | Nature Medicine"}, {"img_url": "https://ars.els-cdn.com/content/image/1-s2.0-S2452302X16300638-gr1.jpg", "img_caption": "Drugs and Devices: Comparison of European and U.S. Approval Processes -  ScienceDirect"}]}
{"catalog": "D:\\project\\AspectMMKG\\Entities\\AstraZeneca\\Vaxzevria, AstraZeneca's COVID-19 pandemic response\\The road to authorisation by the European Medicines Agency", "query": "the National Institute of Allergy and Infectious Diseases (NIAID) confirmed that the third phase of testing for potential vaccines developed by Oxford University and AstraZeneca would begin in July 2020", "images": [{"img_url": "https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1616674202/Coronavirus%20vaccine.jpg/Coronavirus%20vaccine.jpg?VersionId=gX3_dgudaldcSm2N0FsVsESm634iiURs", "img_caption": "AstraZeneca's COVID-19 vaccine defies data controversy with 76%  effectiveness in phase 3 | Fierce Pharma"}, {"img_url": "https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1616501240/GettyImages-1218961180.jpg/GettyImages-1218961180.jpg?VersionId=TXLYNLM4VPrwRDkaEQhIbY5Nqq30oH1K", "img_caption": "AstraZeneca scrambles to update COVID-19 vaccine data after NIH flags  'concerns' about Monday's triumphant release | Fierce Pharma"}, {"img_url": "https://www.gavi.org/sites/default/files/covid/covid-19-vaccines-development-phases.png", "img_caption": "The COVID-19 vaccine race | Gavi, the Vaccine Alliance"}, {"img_url": "https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1641307110/GettyImages-1288838574.jpg/GettyImages-1288838574.jpg?VersionId=JNV5LPUnEv2pYsOknVSpSEypBxOcspsv", "img_caption": "COVID-19 tracker: Japan cancels part of AZ vaccine order | Fierce Pharma"}, {"img_url": "https://images.nature.com/original/magazine-assets/d41587-020-00005-z/d41587-020-00005-z_17818118.jpg", "img_caption": "The pandemic pipeline"}]}
{"catalog": "D:\\project\\AspectMMKG\\Entities\\AstraZeneca\\Vaxzevria, AstraZeneca's COVID-19 pandemic response\\The road to authorisation by the European Medicines Agency", "query": "Oxford–AstraZeneca announced the vaccine's successful trial", "images": [{"img_url": "https://www.news-medical.net/image.axd?picture=2021%2F3%2Fshutterstock_1927027769.jpg", "img_caption": "Oxford-AstraZeneca vaccine effective against B.1.1.7 SARS-CoV-2 variant"}, {"img_url": "https://images.theconversation.com/files/370786/original/file-20201123-15-1yyc7gb.jpg?ixlib=rb-1.1.0&q=45&auto=format&w=1200&h=1200.0&fit=crop", "img_caption": "Why the Oxford AstraZeneca vaccine is now a global gamechanger"}, {"img_url": "https://gdb.voanews.com/79a76d7b-e26f-486e-b4f7-61ef02afc298_w1200_r1.jpg", "img_caption": "AstraZeneca Announces 'Highly Effective' COVID-19 Vaccine"}, {"img_url": "https://ichef.bbci.co.uk/news/976/cpsprodpb/9725/production/_116339683_gettyimages-1230251561.jpg", "img_caption": "Oxford-AZ vaccine 'effective against dominant UK variant' - BBC News"}, {"img_url": "https://d1e00ek4ebabms.cloudfront.net/production/9e503960-f4c0-4eb6-8cd4-a8ed82056593.jpg", "img_caption": "Doubts raised over AstraZeneca-Oxford vaccine data | Financial Times"}]}
{"catalog": "D:\\project\\AspectMMKG\\Entities\\AstraZeneca\\Vaxzevria, AstraZeneca's COVID-19 pandemic response\\The road to authorisation by the European Medicines Agency", "query": "India approved the use of the Oxford–AstraZeneca vaccine", "images": [{"img_url": "https://akm-img-a-in.tosshub.com/businesstoday/images/story/202012/astrazeneca_660_150920084512_301220013933.jpg?size=1200:675", "img_caption": "Oxford-AstraZeneca Covid-19 vaccine approved in UK; nod in India expected  soon - BusinessToday"}, {"img_url": "https://static.independent.co.uk/2020/12/30/18/newFile-3%20%2813%29.jpg?quality=75&width=982&height=726&auto=webp", "img_caption": "India approves Oxford/AstraZeneca vaccine for emergency use in major  breakthrough for Covid fightback | The Independent"}, {"img_url": "https://www.biopharma-reporter.com/var/wrbm_gb_food_pharma/storage/images/_aliases/wrbm_large/publications/pharmaceutical-science/biopharma-reporter.com/article/2021/01/06/oxford-astrazeneca-covid-19-vaccine-granted-emergency-use-authorization-in-multiple-countries/12076064-1-eng-GB/Oxford-AstraZeneca-COVID-19-vaccine-granted-emergency-use-authorization-in-multiple-countries.jpg", "img_caption": "Oxford-AstraZeneca COVID-19 vaccine granted emergency use authorization in  multiple countries"}, {"img_url": "https://images.livemint.com/img/2020/11/23/600x338/AFP_8VP7F4_1606141378479_1606141398688.jpg", "img_caption": "Limited use of Oxford vaccine should be available in India by Dec-end or  early Jan: Serum CEO | Mint"}, {"img_url": "https://media.npr.org/assets/img/2020/11/23/gettyimages-1229653997_sq-58a6df792c34449471d85a4a465e65ab72d6dab9-s800-c85.jpg", "img_caption": "India Authorizes AstraZeneca COVID-19 Vaccine For Emergency Use :  Coronavirus Updates : NPR"}]}
{"catalog": "D:\\project\\AspectMMKG\\Entities\\AstraZeneca\\Vaxzevria, AstraZeneca's COVID-19 pandemic response\\The road to authorisation by the European Medicines Agency", "query": "It was announced that the Oxford–AstraZeneca shot would be made locally by the Serum Institute of India (SII) with a brand name COVISHIELD", "images": [{"img_url": "https://s.france24.com/media/display/22eb5938-4cea-11eb-a10b-005056a98db9/w:1280/p:1x1/2021-01-02T103105Z_1412216785_RC2MZK98T9PA_RTRMADP_3_HEALTH-CORONAVIRUS-INDIA-VACCINE.JPG", "img_caption": "India approves Oxford's AstraZeneca Covid-19 vaccine for emergency use"}, {"img_url": "https://www.euractiv.com/wp-content/uploads/sites/2/2021/03/India-made-AstraZeneca-800x450.jpg", "img_caption": "EU audits Indian vaccine maker as AstraZeneca looks to boost supplies to  the bloc – EURACTIV.com"}, {"img_url": "https://image.cnbcfm.com/api/v1/image/106816643-16091759562020-12-22t175143z_1165207448_rc2hsk9vqdwh_rtrmadp_0_health-coronavirus-india-vaccine.jpeg?v=1609176038&w=1600&h=900", "img_caption": "India approves AstraZeneca and local Covid vaccines, rollout in weeks"}, {"img_url": "https://images.livemint.com/img/2021/01/16/1600x900/367320120_0-5_1610811354867_1610811373397.jpg", "img_caption": "Serum Institute produced 5,000 doses of Covishield every minute. A look at  vaccine journey | Mint"}, {"img_url": "https://assets.bwbx.io/images/users/iqjWHBFdfxIU/inUrQix1D9sI/v1/1200x-1.jpg", "img_caption": "India Should Use the Market to Speed Up Covid-19 Vaccinations - Bloomberg"}]}
